UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------------------
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
----------------------------------------------
Date of Report (Date of earliest event reported): August 6, 1998
MEDICAL INDUSTRIES OF AMERICA, INC.
(Exact name of registrant as specified in its Charter)
FLORIDA 0-20356 65-0158479
(State of other jurisdiction (Commission file no.) (IRS Employer ID
of incorporation) Number)
1903 S. CONGRESS AVENUE, SUITE 400, BOYNTON BEACH, FLORIDA 33426
(Address of principal executive offices)
Registrant's telephone number, including area code: 561-737-2227
<PAGE>
Item 2. Acquisition and Disposition of Assets
(a) Description of Acquisition
On August 6, 1998, the Registrant entered into a merger agreement with
David S. Klein, M.D., P.C. The Registrant will acquire, pursuant to the merger
agreement, 100% of the outstanding stock of David S. Klein, M.D., P.C. for
$3,300,000. One Million Three Hundred Twenty Thousand Dollars ($1,320,000) is
due at closing with the balance of $1,980,000 payable in annual installments
over a three-year period. The purchase price will be paid to the former
shareholder of David S. Klein, M.D., P.C. in the Registrant's restricted common
stock at a value of $1.50 per share. The installment portion of the purchase
price is conditioned upon David S. Klein, M.D., P.C. earning at least $1,100,000
in pre-tax profits in each of the first three years following the closing. If
the earnings threshold is not reached, then the installment payments will be
substantially reduced. The former shareholder has the right to receive up to 45%
of each installment payment in cash.
In addition to the purchase price, the former shareholder has the right to
earn stock options in the Registrant at a rate of 100,000 options per each
$1,000,000 of the consolidated earnings of the Registrant's interventional pain
and sleep business. The options may be exercised at a strike price of $1.50 per
share.
The Registrant also entered into a 3 year employment agreement with David
S. Klein, M.D. at an annual salary of $200,000 plus a profit participation.
Item 7. Financial Statements, Pro Forma Financial Information and
Exhibits
(a) Financial statements of the businesses acquired, prepared
pursuant to Rule 3.05 of Regulation S-X will be filed within 60
days in accordance with Item 7(a) 4.
(b) Pro Forma financial information required pursuant to Article II
of Regulation S-X will be filed within 60 days in accordance
with Item 7(a) 4.
(c) Exhibits
Exhibit Number Description
2 Agreement and Plan of Merger between Medical
Industries of America, Inc., MIOA
Acquisition Company V, Inc., David
S. Klein, M.D.,P.C. and David S.
Klein, M.D.
2.1 Employment Agreement between David S.
Klein, M.D., P.C. and David S. Klein, M.D.
Date: 8/24/98 MEDICAL INDUSTRIES OF AMERICA, INC.
By: /s/ ARTHUR KOBRIN
Arthur Kobrin
Senior Vice President
of Financial Operations
EXHIBIT 2
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
MEDICAL INDUSTRIES OF AMERICA, INC.,
a Florida corporation,
MIOA ACQUISITION COMPANY V, INC.,
a Florida corporation
DAVID S. KLEIN, M.D., P.C.,
a Virginia professional corporation,
AND
DAVID S. KLEIN, M.D.
<PAGE>
AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER (the "AGREEMENT") is entered into this
24th day of August, 1998 by and among MEDICAL INDUSTRIES OF AMERICA, INC., a
Florida corporation or its assigns ("MIOA"), MIOA ACQUISITION COMPANY V, INC., a
Florida corporation (the "ACQUISITION CORP"), DAVID S. KLEIN, M.D., P.C., a
Virginia professional corporation (the "COMPANY") and DAVID S. KLEIN, M.D.
(hereinafter referred to as the "SHAREHOLDER").
RECITALS:
A. The Company is the owner and operator of four (4) medical clinics
(hereinafter the "Clinics") located at and operating under the following
trade names:
Shenandoah Pain Clinic Roanoke Pain Center
109 MacTanly Place 101 Mountain Ave., S.W.
Staunton, VA 24401 Suite 3
Roanoke, VA 24022
Albemarle Pain Center Rockingham Pain Center
1265 Seminole Trail 861 Cantrell Ave.
Charlottesville, VA 22906 Harrisonburg, VA 22801
B. The Company provides pain, physical rehabilitation and other related
services (the "Business") at the Clinics.
C. The principal business location of the Company is 109 MacTanly Place,
Staunton, VA 24401 (the "Principal Business Location").
D. The Company's billing and administrative offices are located at 13 W.
Beverley Street, Masonic Lodge, 2nd floor, Staunton, VA 24401.
E. Shareholder owns one hundred (100) shares of common stock, $1.00 par value
per share, of the Company (the "Klein Shares"), which shares represent one
hundred percent (100%) of the outstanding shares of capital stock of the
Company.
F. The Company will, immediately after the execution of this Agreement, file
Articles of Amendment with the Virginia State Corporation Commission
("SCC") changing the status of the Company from a Virginia professional
corporation to a standard for-profit Virginia corporation and
contemporaneously therewith file Articles of Merger with the SCC thereby
statutorily merging the Company into MIOA's wholly owned-subsidiary,
Acquisition Corp, (such merger being referred to herein as the "Merger").
The Merger shall be in accordance with this Agreement, the articles of
merger, the Florida Business Corporation Act (the "FLORIDA STATUTE") and
the corporate statute of the State of Virginia (the "VIRGINIA STATUTE").
1
<PAGE>
G. MIOA presently owns and upon consummation of the Merger will own 100% of
all authorized, issued and outstanding Acquisition Corp stock. The
Shareholder shall receive in exchange shares of MIOA restricted voting
common stock, no par value (the "MIOA STOCK" or the "MIOA SHARES") in
accordance with the terms and conditions hereof.
H. The Merger shall constitute a "B" Reorganization structured as a "forward
subsidiary merger" pursuant to Section 368(a)(1)(B) of the Internal
Revenue Code, as amended.
ARTICLE I.
THE MERGER
1.1. THE MERGER. As of the Effective Date (as hereinafter defined)
and in accordance with the applicable provisions of the Florida Statute and the
Virginia Statute, the Company shall be merged with and into the Acquisition
Corp, in accordance with the terms and conditions of this Agreement and the
articles of merger in substantially the form of EXHIBIT A annexed hereto,
subject to such changes as to form (but not substance) as may be required by the
Florida Statute and the Virginia Statute, hereinafter referred to as the
"ARTICLES OF MERGER". The Acquisition Corp shall be the surviving corporation of
the Merger (the Acquisition Corp, in such capacity, being hereinafter sometimes
referred to as the "SURVIVING CORPORATION"). Thereupon, the separate existence
of the Company shall cease, and the Acquisition Corp, as the Surviving
Corporation, shall continue its corporate existence under the Florida Statute
under its amended name as provided in said Articles of Merger, to wit "VALLEY
PAIN CENTERS OF AMERICA, INC."
1.2. EFFECTIVENESS OF THE MERGER. As soon as practicable upon or
after the satisfaction or waiver of the conditions precedent set forth in
Articles VII and VIII of this Agreement, the Company shall execute an amendment
to its Articles of Incorporation changing the status of the Company from a
Virginia professional corporation to a Virginia for-profit corporation and
contemporaneously therewith, the Acquisition Corp and the Company will execute
appropriate Articles of Merger, and shall file or cause to be filed such
Articles of Amendment and Merger with the Secretary of State of Florida and the
State Corporation Commission of Virginia; and, the subject Merger shall become
effective as of the later of (i) the filing of the Articles of Merger with the
Secretary of the State of Florida or (ii) the approval by Virginia SCC of the
Company's Articles of Merger.
1.3 EFFECT OF THE MERGER. Upon the effectiveness of the Merger,
(a) the Surviving Corporation shall own and possess all assets and property of
every kind and description, and every interest therein, wherever located, and
all rights, privileges, immunities, powers, franchises and authority of a public
as well as of a private nature, of the Acquisition Corp and the Company (the
"CONSTITUENT CORPORATIONS"), and all obligations owed to, belonging to or due to
each of the Constituent Corporations, all of which shall be vested in the
Surviving Corporation pursuant to Florida Statute and Virginia Statute without
further act or deed, and (b) the Surviving Corporation shall be liable for all
claims, liabilities and obligations of the Constituent Corporations, all of
which shall become and remain the obligations of the Surviving Corporation
pursuant to Florida Statute and Virginia Statute without further act or deed.
2
<PAGE>
1.4. SURVIVING CORPORATION. Upon the effectiveness of the Merger,
the Articles of Incorporation and Bylaws of the Surviving Corporation shall be
identical to those attached hereto as EXHIBITS B AND C, respectively. The
directors of the Surviving Corporation initially shall be Rogers W. Kirven, Jr.,
David S. Klein, M.D., Paul Pershes, E. Nicholas Davis, III and Arthur Kobrin
each of whom shall continue to be the directors of the Surviving Corporation,
subject to the Articles of Incorporation, and the Bylaws.
1.5. SUBSEQUENT ACTIONS. If at any time after the Effective Date,
the Surviving Corporation shall consider or be advised that any deeds, bills of
sale, assignments, assurance or any other actions or things are necessary or
desirable to (i) vest, perfect or confirm of record or otherwise in the
Surviving Corporation its right, title or interest in, to or under any of the
rights, properties or assets of either Acquisition Corp or the Company acquired
or to be acquired by the Surviving Corporation as a result of, or in connection
with, the Merger or (ii) otherwise to carry out this Agreement, then the
officers and directors of the Surviving Corporation shall be authorized to (x)
execute and deliver, in the name and on behalf of either the Acquisition Corp or
the Company, as the case may be, all such deeds, bills of sale, assignments and
assurances and (y) to take and do, in the name of and on behalf of each
corporation or otherwise, all such actions and things as may be necessary or
desirable, to vest, perfect or confirm any and all right, title and interest in,
to and under such rights, properties or assets in the Surviving Corporation or
otherwise to carry out this Agreement.
1.6. STATUS AND CONVERSION OF SHARES. Upon the Effective Date of the
Merger:
(a) Each share certificate representing each outstanding
share of Acquisition Corp shall continue to be a share of issued and outstanding
Common Stock of the Surviving Corporation and shall be retained by MIOA (the
"ACQUISITION CORP STOCK").
(b) The share certificates representing all the outstanding
shares of capital stock of the Company (i.e., the KLEIN SHARES) issued and
outstanding immediately prior to the effectiveness of the Merger shall, by
virtue of the Merger and without any action on the part of the holder thereof,
be deemed canceled and extinguished. In exchange for the merger of the Company
into the Acquisition CORP, the Shareholder shall receive the Merger
Consideration set forth and defined in Section 2.1 below (the "MERGER
CONSIDERATION").
1.7. BOOKS AND RECORDS. On the Effective Date (as hereinafter
defined), the Company shall deliver to MIOA all of the stock books, records and
minute books of the Company, all financial and accounting books and records of
the Company, all tax returns and records of the Company, and all supplier,
client, customer, sales and other business records of the Company.
3
<PAGE>
ARTICLE II.
MERGER CONSIDERATION
2.1. SHAREHOLDER MERGER CONSIDERATION. In exchange for merging the
Company into the Acquisition Corp and canceling and extinguishing the Klein
Shares in accordance with this Merger Agreement, the Shareholder shall receive
the following Merger Consideration:
(a) MIOA agrees, subject to the provisions of this
Agreement, to pay to the Shareholder an amount up to, but not exceeding, Three
Million Three Hundred Thousand Dollars ($3,300,000.00) (hereinafter the
"Purchase Price") as set forth below. The Purchase Price is based upon the
representation of Shareholder that the Surviving Company will have Formula
Profits (as defined below) of at least One Million One Hundred Thousand Dollars
($1,100,000.00) for each Formula Period (prorated for Formula Periods of less
than one year) (as defined below). The Purchase Price shall be paid as follows:
(I) INITIAL PAYMENT. On the Effective Date, MIOA
will pay the Shareholder One Million Three Hundred Twenty Thousand Dollars
($1,320,000.00) (the "Initial Payment");
(II) INSTALLMENT PAYMENTS. On the Effective Date,
MIOA will grant the Shareholder the right to earn the remaining unpaid portion
of the Purchase Price of One Million Nine Hundred Eighty Thousand Dollars
($1,980,000.00) (hereinafter the "Installment Payments") during the Formula
Periods in accordance with the following formula:
A. INSTALLMENT FORMULA:
1. In respect to Formula Period 1:(x) If
Formula Profits equal the product of One Million One Hundred Thousand Dollars
($1,100,000.00) multiplied by the Prorated Percentage (defined below), MIOA will
pay the Shareholder an amount equal to the product of Six Hundred Sixty Thousand
Dollars ($660,000.00) multiplied by the Prorated Percentage; (y) If Formula
Profits exceed the product of One Million One Hundred Thousand Dollars
($1,100,000.00) multiplied by the Prorated Percentage (defined below), MIOA will
pay the Shareholder an amount equal to the product of Six Hundred Sixty Thousand
Dollars ($660,000.00) multiplied by the Prorated Percentage plus One Dollar
($1.00) for each Dollar in excess of the product of One Million One Hundred
Thousand Dollars ($1,100,000.00) multiplied by the Prorated Percentage (defined
below);or, (z) If Formula Profits are less than the product of the Prorated
Percentage multiplied by One Million One Hundred Thousand Dollars
($1,100,000.00), the amount the Shareholder shall receive shall be equal to:
sixty-seven percent (67%) of the Formula Profits for Formula Period 1 divided by
the product of the Prorated Percentage multiplied by One Million One Hundred
Thousand Dollars ($1,100,000.00) with the resulting quotient multiplied by the
product of the Prorated Percentage multiplied by Six Hundred Sixty Thousand
Dollars ($660,000.00). For these purposes the "Prorated Percentage" shall be a
fraction the numerator of which shall equal the number of days from the
Effective Date through March 31, 1999 and the denominator of which shall equal
365.
4
<PAGE>
2. In respect to Formula Period 2: (x) If
Formula Profits equal One Million One Hundred Thousand Dollars ($1,100,000.00),
MIOA will pay the Shareholder the sum of Six Hundred Sixty Thousand Dollars
($660,000.00); (y) If Formula Profits exceed One Million One Hundred Thousand
Dollars ($1,100,000.00), MIOA will pay the Shareholder the sum of Six Hundred
Sixty Thousand Dollars ($660,000.00) plus One Dollar ($1.00) for each Dollar in
excess of One Million One Hundred Thousand Dollars ($1,100,000.00) or, (z) If
Formula Profits are less than One Million One Hundred Thousand Dollars
($1,100,000.00), the amount the Shareholder shall receive shall be equal to:
sixty-seven percent (67%) of the Formula Profits for Formula Year 2 divided by
One Million One Hundred Thousand Dollars ($1,100,000.00) with the resulting
quotient multiplied by Six Hundred Sixty Thousand Dollars ($660,000.00).
3. In respect to Formula Period 3, apply the
formula enumerated for Formula Period 2 above, substituting where appropriate
Period 3 for Period 2.
4. The installment payments in respect to
Formula Period 4, shall be calculated on the same basis as Formula Period 1,
except that the Prorated Percentage shall be equal to a fraction the numerator
of which will be the number of days in Formula Period 4 and the denominator of
which shall be equal to 365.
5. The foregoing notwithstanding, the
maximum amount of Installment Payments the Shareholder may receive shall not
exceed One Million Nine Hundred Eighty Thousand Dollars ($1,980,000.00). In
addition, in the event MIOA or any successor company causes the Surviving
Company to undertake a Spin-Off (as hereinafter defined) or Offering (as
hereinafter defined) of its stock prior to the expiration of the Formula
Periods, the Shareholder shall be paid the portion of the unpaid Purchase Price
immediately prior to the Spin-Off or Offering by applying the above formula to
the proforma Formula Profits for the remainder of the Formula Periods calculated
based on the immediately preceding twelve (12) month period or such shorter
period if less than 12 months. The term "SPIN-OFF" shall mean a spin-off of all
or a part of the Surviving Company's capital stock owned by MIOA to the public
shareholders of MIOA resulting in the Surviving Company becoming a separate and
independent (non-subsidiary) corporation. The term "OFFERING" shall mean a
public offering of the Surviving Company's equity securities. These defined
terms shall also include a merger and/or roll-up of the Surviving Corporation
with Ivanhoe Medical Systems, Inc. ("Ivanhoe") for the purpose of undertaking a
"SPIN-OFF" or "OFFERING" of Ivanhoe.
5
<PAGE>
A. FORMULA PROFITS. For the purposes of this
Agreement, the term "FORMULA PROFITS" shall mean the pre-tax net profits of
Surviving Company, as calculated utilizing generally accepted accounting
principles by the Surviving Company's independent certified public accountants
for annual Formula Periods, where possible, and as calculated for MIOA's 10Q for
quarterly Formula Periods. Notwithstanding the foregoing, for purposes of
determining Formula Profits: (i) there shall not be included any charge for
corporate overhead of MIOA or other administrative or similar charges that MIOA
might impose upon the Surviving Company except those charges for which the
Surviving Company receives a direct and cost efficient benefit, (ii) there shall
not be included any non-recurring charges, losses, profits, gains, or non-cash
adjustments not related to the ongoing operations of the business, including,
but not limited to discount operations, extraordinary items, acquisition costs,
goodwill charges, or unusual or infrequent items as they are defined under
generally accepted accounting principles, and (iii) there shall not be included
any charge related to grants or exercises of options pursuant to this Agreement.
B. FORMULA PERIODS. The period commencing on
the Effective Date, 1998 and ending on March 31, 1999 shall be deemed to be
"FORMULA PERIOD 1". The two immediately succeeding twelve (12) month periods
following Formula Period 1 shall be deemed to be "Formula Period 2" and "Formula
Period 3", respectively. Formula Period 4 shall be the period from April 1, 2001
though such day in 2001 which when added to Formula Period 1 would result in a
period equal to 12 complete months.
C. CALCULATION TIMING. MIOA, Surviving
Company and Shareholder shall each work in good faith to derive the calculations
required hereunder, it being understood and agreed that MIOA shall cause such
calculations to be made and payments to the Shareholder be made no later than
the 90th day following each Formula Period.
D. EXAMPLE. Attached hereto as EXHIBIT A and
incorporated herein by this reference is an example of how the aforementioned
Formula should be applied.
(III) PAYMENT OF PURCHASE PRICE. One hundred percent
(100%) of the Purchase Price shall be made with restricted voting common stock
(the "Shares") of MIOA. For purposes of determining the number of MIOA Shares
the Shareholder will receive in respect to a given payment, the following
calculation shall be made: the amount of the Purchase Price which is due at the
time shall be divided by One Dollar and Fifty Cents ($1.50); the resulting
quotient is the number of MIOA Shares that shall be delivered to the Shareholder
in respect to such payment.
6
<PAGE>
(IV) PUT OPTION. Notwithstanding the foregoing and
provided such cash payment does not adversely affect the tax consequences of the
Shareholder in respect to this transaction, the Shareholder shall have the
option within 30 days of the date of calculating any Installment Payment due
herein in respect of any given Formula Period to elect, by providing written
notice to MIOA, to have up to forty-five percent (45%) of any given Installment
Payment due Shareholder paid in cash at the rate of seventy-five cents ($0.75)
for each dollar earned. For example, if the Shareholder would otherwise be
entitled to $660,000 by electing to be paid 100% in cash in respect to such
payment, the Shareholder would receive $222,750.00. MIOA shall be entitled to
pay the cash portion of any installment payment in six (6) equal consecutive
monthly payments without interest beginning on the first day of the second month
immediately following such election by the Shareholder.
(V) EARN-UP OPTIONS. Contemporaneous with the execution
of this Agreement, Rogers W. Kirven, Jr., as Trustee, and Shareholder will enter
into a non-qualified stock option agreement in substantially the same form as
attached hereto as Exhibit "C" (the "Option Agreement") whereby Mr. Kirven, as
Trustee, will grant Shareholder the right to earn options to purchase additional
shares of MIOA's restricted common stock (the "Earn-up Options") during the
Formula Periods. In general terms, the options shall be earned at the rate of
100,000 options for each $1,000,000.00 of "Consolidated Ivanhoe Incremental
Formula Profits" (as that term is defined in the Option Agreement). The Earn-up
Options may be exercised at a strike price of $1.50 per share. The Option
Agreement will dictate the exact terms and conditions relative to the Earn-up
Options.
(VI) CONVERSION PRIVILEGES. Contemporaneous with a
Spin-Off or Offering of Ivanhoe, the Shareholder shall be entitled to exchange
the Applicable Amount (as defined below) of his MIOA Shares for the Ivanhoe (or
any successor company) common capital stock which shall be made available to the
Ivanhoe shareholders and affiliates including Shareholder immediately preceding
the Spin-Off or Offering. Such Ivanhoe common stock shall not be less than ten
percent (10%) of the total issued and outstanding stock of the Ivanhoe (or its
successor company) on a fully diluted basis immediately prior to such Spin-off
or Offering (the "Offered Shares"). The Shareholder's Applicable Amount shall be
calculated by multiplying the number of Offered Shares by a fraction the
numerator of which shall be the Formula Profits of the Surviving Company for the
twelve (12) month period immediately preceding the date of determining the
number of Offered Shares and the denominator of which shall be total
Consolidated Ivanhoe (which shall include the Surviving Company) pre-tax net
profits for the same period. The Consolidated Ivanhoe pre-tax net profits shall
mean the pre-tax profits of Ivanhoe, its subsidiaries and all other MIOA
subsidiaries which are predominately in the sleep apnea and interventional pain
business and which are considered to be Ivanhoe affiliates by virtue of the fact
that the management of such subsidiaries is under the direction of Ivanhoe and
its principals. In determining the exchange price, the per share value of the
MIOA Shares shall be valued at the average bid price for the thirty (30)
business days immediately preceding the date of determining the number of
Offered Shares and the per share value of the Ivanhoe Stock shall be valued at
eighty percent (80%) of the price per share which will be offered in the
Spin-Off or Offering.
7
<PAGE>
To illustrate this section, assume the following:
A. Surviving Company Formula Profits $2,000,000;
B. The Consolidated Ivanhoe pre-tax profits
$4,000,000; C. 400,000 shares of Offered Shares;
D. Average bid price of MIOA Shares: $5.00;
E. Offering Price of the Ivanhoe stock to the public
$8.00.
Assuming the foregoing, Shareholder's Applicable
Amount would be $1,280,000.00 ([$2,000,000/$4,000,000 x 400,000] x [$8.00 x
.80]). Thus, the Shareholder would have to exchange 256,000 shares of his MIOA
Shares to acquire 200,000 shares (i.e., $1,280,000) of the Offered Shares.
(vii) CAPITAL ADJUSTMENTS AFFECTING INSTALLMENT
SHARES AND EARN-UP OPTIONS.
A. The existence of the MIOA Shares or Earn-up
Options shall not affect in any way the right or power of the Surviving Company
or MIOA to make or authorize any or all adjustments, recapitalizations,
reorganizations or other changes in the Surviving Company's or MIOA's capital
structure or their business, or any merger or consolidation of the Surviving
Company or MIOA or to issue any securities, bonds, debentures, or preferred or
prior preference stock ahead of or affecting the common stock of the Surviving
Company or MIOA, the rights thereof or to effect the dissolution or liquidation
of the Surviving Company or MIOA, or any sale or transfer of all or part of
their assets or business, or any other corporate act or proceeding, whether of a
similar character or otherwise.
B. In the event of a stock dividend,
recapitalization, or merger in which MIOA is the surviving corporation,
split-up, combination or exchange of shares or the like which results in a
change in the number or kind of shares of common stock which is outstanding
immediately prior to such event, the aggregate number and kind of MIOA Shares
owned by the Shareholder and the rights of the Shareholder to receive additional
MIOA Shares in respect to the Purchase Price and the rights of Shareholder
relative to the Earn-up Options (hereinafter the "Earn-up Rights") and the price
thereof, shall be appropriately adjusted in the same manner as the number and
kind of shares of a shareholder of MIOA who owned the same number and kind of
shares immediately prior to such event or an option holder of MIOA who owned
like options immediately prior to such event. Such adjustments shall be made by
the Board of Directors of MIOA, whose determination shall be conclusive and
binding on all parties.
8
<PAGE>
C. Except as otherwise expressly provided herein,
the issuance of shares of MIOA's capital stock of any class, or securities
convertible into shares of capital stock of any class, either in connection with
direct sale or upon the exercise of rights or warrants to subscribe therefor, or
upon conversion of shares or obligations of MIOA convertible into such shares or
other securities, shall not affect, and no adjustment by reason thereof shall be
made with respect to the number of or price to the MIOA Shares the Shareholder
then owns or his rights in respect to additional MIOA Shares or to Shareholder
with respect to the number of or price of the Earn-up Rights or any Earn-up
Options.
D. In case of any consolidation or merger of MIOA
with or into another corporation or the conveyance of all or substantially all
of the assets of MIOA to another corporation or a share exchange transaction
involving not less than 50% of the issued and outstanding common stock of MIOA,
the MIOA Shares and Earn-up Options shall thereafter be convertible into the
number of shares of stock, options or other securities or property to which a
holder of the number of shares of common stock deliverable upon entitlement to
the MIOA Shares or Earn-up Options, as the case may be, would have been entitled
upon such consolidation, merger, conveyance or exchange; and, in any such case,
appropriate adjustment shall be made in the application of the provisions herein
set forth with respect to the rights and interest thereafter of the holders of
rights to receive additional MIOA Shares and Option Rights, to the end that the
provisions set forth herein shall thereafter be applicable, as nearly as
reasonably may be, in relation to any shares of stock, options or other property
thereafter deliverable upon entitlement to the MIOA Shares and Earn-up Options,
as the case may be.
2.2. NO REGISTRATION. The Shareholder acknowledges and agrees that:
(a) Except as otherwise provided herein, the MIOA Shares and
the Earn-up Options (collectively hereafter called the "MIOA Securities") are
being granted and issued without registration under applicable federal and state
securities laws in reliance upon certain exemptions from registration under such
securities laws;
(b) Each certificate representing the MIOA Securities will
bear a legend restricting its transfer, sale, conveyance or hypothecation,
unless such MIOA Securities are either registered under applicable securities
laws or an exemption from such registration is applicable;
(c) The Shareholder shall not transfer all or any of the MIOA
Securities except in compliance with all applicable securities laws including
Rule 144 of the Securities Act of 1933. Rule 144 presently allows a sale, within
certain limitations, of the MIOA Securities after one (1) year from the date the
MIOA Securities are unconditionally earned pursuant to this agreement;
9
<PAGE>
(d) The Shareholder is acquiring the MIOA Securities for his
own account, for investment purposes only and not with a view to the sale or
distribution thereof.
2.3. CLOSING. Consummation of the contemplated transaction (the
"CLOSING") shall take place on August 7, 1998 or on such other date or at such
other time or place as may be mutually agreed upon in writing by the parties
hereto (the "CLOSING DATE"). Notwithstanding the foregoing Closing Date, the
subject Merger shall become effective as of the later of (i) the filing of the
Articles of Merger with the Secretary of the State of Florida or (ii) the
approval by Virginia SCC of the Company's Articles of Merger (the "EFFECTIVE
DATE").
ARTICLE III
REPRESENTATIONS AND WARRANTIES
OF THE COMPANY AND SHAREHOLDER
The Company and the Shareholder, jointly and severally, make the following
representations and warranties to MIOA, each of which is true and correct on the
date hereof, shall remain true and correct to and including the Closing Date,
shall be unaffected by any investigation heretofore or hereafter made by MIOA,
or any knowledge of MIOA other than as specifically disclosed herein or in the
disclosure schedules delivered to MIOA, and shall survive the Closing of the
transactions provided for herein until the end of Formula Period 4.
3.1 KLEIN SHARES. The Shareholder is the owner of the Klein Shares free
and clear of any direct or indirect claims, liens, security interests, charges,
pledges or encumbrances of any nature whatsoever and will be free of such
claims, liens, security interests, charges, pledges or encumbrances as of the
Effective Date. All of the Klein Shares are validly issued to the Shareholder,
fully paid and nonassessable. There are no existing options, calls, rights or
commitments of any character relating to the Klein Shares or any Company
securities of any kind.
3.2 ORGANIZATION. The Company is a professional corporation duly
organized, validly existing and in good standing under the laws of the State of
Virginia and is validly qualified or licensed in each jurisdiction wherein the
character of the property owned or leased by it, or the nature of its business,
makes such licensing or qualification necessary. Accurate, current and complete
copies of the Articles of Incorporation and Bylaws of the Company are attached
hereto as SCHEDULE 3.2.
10
<PAGE>
3.3 CAPITALIZATION. The authorized capital stock of the Company consists
of Ten Thousand (10,000) shares of common stock, $1.00 par value per share (the
"Company Stock"), One Hundred (100) shares of which are issued and outstanding.
No shares of capital stock or other equity securities of the Company are issued,
reserved for issuance or outstanding. All outstanding shares of capital stock of
the Company are duly authorized, validly issued, fully paid and nonassessable
and, not subject to preemptive rights. There are no outstanding bonds,
debentures, notes or other indebtedness or other securities of the Company
having the right to vote (or convertible into, or exchangeable for, securities
having the right to vote) on any matters on which shareholders of the Company
may vote. Except as set forth above, there are no outstanding securities,
options, warrants, calls, rights, commitments, agreements, arrangements or
undertakings of any kind to which the Company is a party or by which it is bound
obligating the Company to issue, deliver or sell, or cause to be issued,
delivered or sold, additional shares of capital stock or other equity securities
of the Company or obligating the Company to issue, grant, extend or enter into
any such security, option, warrant, call, right, commitment, agreement,
arrangement or undertaking. There are no outstanding contractual obligations,
commitments, understandings or arrangements of the Company to repurchase, redeem
or otherwise acquire or make any payment in respect of any shares of capital
stock of the Company. A complete list of security holders of the Company and
their addresses is attached hereto as SCHEDULE 3.3.
3.4 AUTHORITY AND APPROVAL OF AGREEMENT.
(a) The execution and delivery of this Agreement by the Company and
the Shareholder and the performance of all the Company's and the Shareholder's
obligations hereunder have been duly authorized and approved by all requisite
corporate action on the part of the Company and the Shareholder pursuant to
applicable law. The Company and the Shareholder have the power and authority to
execute and deliver this Agreement and to perform all their obligations
hereunder.
(b) This Agreement and any other documents, instruments and
agreements executed by the Company and the Shareholder in connection herewith
constitute the valid and legally binding agreements of the Company and the
Shareholder, enforceable against the Company and the Shareholder in accordance
with their terms, except that (i) enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws of general
application affecting the enforcement of the rights and remedies of creditors;
and (ii) the availability of equitable remedies may be limited by equitable
principles.
3.5 NO VIOLATIONS. Neither the execution, delivery nor performance of this
Agreement or any other documents, instruments or agreements executed by the
Shareholder and the Company in connection herewith, nor the consummation of the
transactions contemplated hereby: (a) will violate any statute, law, ordinance,
rule or regulation (collectively, "Laws") or any order, writ, injunction,
judgment, plan or decree (collectively, "Orders") of any court, arbitrator,
department, commission, board, bureau, agency, authority, instrumentality or
other body, whether federal, state, municipal, foreign or other (collectively,
"Government Entities"), (b) subject to obtaining the approval of the SCC, will
require any authorization, consent, approval, exemption or other action by or
notice to any Government Entity; (c) subject to obtaining the consents referred
to in this Agreement, will violate or conflict with, or constitute a default (or
an event which, with notice or lapse of time, or both, would constitute a
default) under, or will result in the termination of, or accelerate the
performance required by, or result in the creation of any Lien (as hereinafter
defined) upon any of the assets of the Company (or the Klein Shares) under any
term or provision of the Articles of Incorporation or By-Laws of the Company or
of any contract, commitment, understanding, arrangement, agreement or
restriction of any kind or character to which the Company or the Shareholder is
a party or by which the Company or the Shareholder or any of its or his assets
or properties may be bound or affected; or (d) will or could result in the loss
or adverse modification of, or the imposition of any fine or penalty with
respect to, any license, permit or franchise granted or issued to, or otherwise
held by or for the use of, the Company.
11
<PAGE>
3.6 FINANCIAL STATEMENTS. Included as SCHEDULE 3.6 are true and complete
copies of the unaudited financial statements of the Company consisting of (i)
balance sheets of the Company as of December 31, 1997, 1996, and 1995 and the
related statements of operations and cash flows for the years then ended
(including the notes contained therein or annexed thereto), and (ii) an
unaudited balance sheet of the Company as of July 31, 1998 (the "Recent Balance
Sheet"), and the related unaudited statements of operations and cash flows for
the seven (7) months then ended (the "Recent Statement of Operations") and for
the corresponding period of the prior year (including the notes and schedules
contained therein or annexed thereto). All of such financial statements
(including all notes and schedules contained therein or annexed thereto) are
true, complete and accurate, have been prepared in accordance with generally
accepted accounting principles applied on a consistent basis, have been prepared
in accordance with the books and records of the Company, and fairly present, in
accordance with generally accepted accounting principles, the assets,
liabilities and financial position, the results of operations and cash flows of
the Company as of the dates and for the years and periods indicated.
3.7 CONDUCT SINCE DATE OF RECENT BALANCE SHEET. Except for this Agreement
and as disclosed in SCHEDULE 3.7 hereto, none of the following has occurred
since the date of the Recent Balance Sheet:
(a) NO ADVERSE CHANGE. Any material adverse change in the financial
condition, assets, liabilities, business, prospects or operations of the
Company;
(b) NO DAMAGE. Any loss, damage or destruction, whether covered by
insurance or not, affecting the Company's business or properties;
(c) NO INCREASE IN COMPENSATION. Except as described in SCHEDULE
3.7(C), any increase in the compensation, salaries or wages payable or to become
payable to any employee or agent of the Company (including, without limitation,
any increase or change pursuant to any bonus, pension, profit sharing,
retirement or other plan or commitment), or any bonus or other employee benefit
granted, made or accrued;
(d) NO LABOR DISPUTES. Any labor dispute or disturbance, other than
routine individual grievances which are not material to the business, financial
condition or results of operations of the Company.
12
<PAGE>
(e) NO COMMITMENTS. Any commitment or transaction by the Company
(including, without limitation, any borrowing or capital expenditure) other than
in the ordinary course of business consistent with past practice;
(f) NO DIVIDENDS. Except as described in SCHEDULE 3.7(F), any
declaration, setting aside, or payment of any dividend or any other distribution
in respect of the Company's capital stock; any redemption, purchase or other
acquisition by the Company of any capital stock of the Company, or any security
relating thereto; or any other payment to any shareholder of the Company as such
a shareholder;
(g) NO DISPOSITION OF PROPERTY. Any sale, lease or other transfer or
disposition of any properties or assets of the Company, except in the ordinary
course of business;
(h) NO INDEBTEDNESS. Any indebtedness for borrowed money
incurred, assumed or guaranteed by the Company;
(i) NO LIENS. Any mortgage, pledge, lien or encumbrance made
on any of the properties or assets of the Company;
(j) NO AMENDMENT OF CONTRACTS. Any entering into, amendment or
termination by the Company of any contract, or any waiver of material rights
thereunder, other than in the ordinary course of business;
(k) LOANS AND ADVANCES. Any loan or advance (other than advances to
employees in the ordinary course of business for travel and entertainment in
accordance with past practice) to any person including, but not limited to, any
Affiliate (for purposes of this Agreement, the term "Affiliate" shall mean and
include all shareholders, directors and officers of the Company; the spouse of
any such person; any person who would be the heir or descendant of any such
person if he or she were not living; and any entity in which any of the
foregoing has a direct or indirect interest);
(l) CREDIT. Any grant of credit to any customer or distributor on
terms or in amounts more favorable than those which have been extended to such
customer or distributor in the past, any other change in the terms of any credit
heretofore extended, or any other change of the Company's policies or practices
with respect to the granting of credit; or
(m) NO UNUSUAL EVENTS. Any other event or condition not in the
ordinary course of business of the Company.
3.8 SUBSIDIARIES. The Company has no subsidiaries. It does not own or
control, directly or indirectly, any capital stock of any corporation or
interest in any partnership, trust or unincorporated association, or any
interest or investment in any other corporation, association or other business
entity.
13
<PAGE>
3.9 LIABILITIES. Except as and to the extent specifically disclosed in the
Recent Balance Sheet, or in SCHEDULE 3.9, the Company does not have any
liabilities, commitments or obligations (secured or unsecured, and whether
accrued, absolute, contingent, direct, indirect or otherwise), other than
commercial liabilities and obligations incurred since the date of the Recent
Balance Sheet in the ordinary course of business and consistent with past
practice and none of which has or will have a material adverse effect on the
business, financial condition or results of operations of the Company. Except as
and to the extent described in the Recent Balance Sheet or in SCHEDULE 3.9,
neither the Company nor the Shareholder has knowledge of any basis for the
assertion against the Company of any liability and neither has knowledge of any
circumstances, conditions, happenings, events or arrangements, contractual or
otherwise, which may give rise to liabilities, except commercial liabilities and
obligations incurred in the ordinary course of the Company's business and
consistent with past practice.
3.10 TITLE TO AND CONDITION OF PROPERTIES.
a. MARKETABLE TITLE. The Company has good and marketable title to
all of the Company's assets, business and properties, including, without
limitation, all such properties (tangible and intangible) reflected in the
Recent Balance Sheet, except for items disposed of in the ordinary course of
business since the date of such Recent Balance Sheet, free and clear of all
mortgages, liens, (statutory or otherwise) security interests, claims, pledges,
licenses, equities, options, conditional sales contracts, assessments, levies,
easements, covenants, reservations, restrictions, rights-of-way, exceptions,
limitations, charges or encumbrances of any nature whatsoever (collectively,
"Liens") except those described in SCHEDULE 3.10. None of the Company's assets,
business or properties are subject to any restrictions with respect to the
transferability thereof, except as otherwise provided for herein; and the
Company's title thereto will not be affected in any way by the transactions
contemplated hereby.
b. CONDITION. All property and assets owned, leased or otherwise
utilized by the Company are in good operating condition and repair, free from
any defects (except such minor defects as do not interfere with the use thereof
in the conduct of the normal operations of the Company), have been maintained
consistent with the standards generally followed in the industry and are
sufficient to carry on the Business of the Company as conducted during the
preceding 12 months. All buildings, plants and other structures owned or
otherwise utilized by the Company are in good condition and repair and to the
best of the Company's and the Shareholder's knowledge, have no structural
defects or defects affecting the plumbing, electrical, sewerage, or heating,
ventilating or air conditioning systems.
3.11 ACCOUNTS RECEIVABLE. All accounts receivable of the Company reflected
on the Recent Balance Sheet, and as incurred in the normal course of business
since the date thereof, represent arm's length sales actually made in the
ordinary course of business; are collectible (net of the reserve shown on the
Recent Balance Sheet for doubtful accounts) in the ordinary course of business
without the necessity of commencing legal proceedings; are subject to no
counterclaim or setoff; and are not in dispute. SCHEDULE 3.11 contains an aged
schedule of accounts receivable included in the Recent Balance Sheet.
14
<PAGE>
3.12 CONTRACTS AND COMMITMENTS.
(a) REAL PROPERTY LEASES. Except as set forth in SCHEDULE
3.18, the Company has no leases of real property.
(b) PERSONAL PROPERTY LEASES. Except as set forth in SCHEDULE
3.12(B), the Company has no leases of personal property involving consideration
or other expenditure in excess of $10,000.00 or involving performance over a
period of more than six (6) months.
(c) PURCHASE COMMITMENTS. The Company has no purchase commitments
for inventory items or supplies that, together with amounts on hand, constitute
in excess of two (2) months normal usage, or which are at an excessive purchase
price.
(d) SALES COMMITMENTS. The Company has no sales contracts or
commitments to customers which aggregate in excess of $10,000.00 to any one
customer (or group of affiliated customers). The Company has no sales contracts
or commitments except those made in the ordinary course of business, at arm's
length, and no such contracts or commitments are for a sales price which would
result in a loss to the Company.
(e) CONTRACTS WITH AFFILIATES AND CERTAIN OTHERS. The Company has no
agreement, understanding, contract or commitment (written or oral) with any
Affiliate or any employee, agent, consultant, distributor or dealer that is not
cancelable by the Company on notice of not longer than 30 days without
liability, penalty or premium of any nature or kind whatsoever.
(f) POWERS OF ATTORNEY. The Company has not given a power of
attorney, which is currently in effect, to any person, firm or corporation for
any purpose whatsoever.
(g) LOAN AGREEMENTS. Except as set forth in SCHEDULE 3.12 (G), the
Company is not obligated under any loan agreement, promissory note, letter of
credit, or other evidence of indebtedness as a signatory, guarantor or
otherwise.
(h) GUARANTEES. Except as disclosed on SCHEDULE 3.12 (H), the
Company has not guaranteed the payment or performance of any person, firm or
corporation, agreed to indemnify any person or act as a surety, or otherwise
agreed to be contingently or secondarily liable for the obligations of any
person.
(i) GOVERNMENT CONTRACTS. The Company is not a party to any
contract with any governmental body.
(j) BURDENSOME OR RESTRICTIVE AGREEMENTS. The Company is not a party
to nor is it bound by any agreement, deed, lease or other instrument which is so
burdensome as to materially affect or impair the operation of the Company.
Without limiting the generality of the foregoing, the Company is not a party to
nor is it bound by any agreement requiring the Company to assign any interest in
any trade secret or proprietary information, or prohibiting or restricting the
Company from competing in any business or geographical area or soliciting
customers or otherwise restricting it from carrying on its business anywhere in
the world.
15
<PAGE>
(k) OTHER MATERIAL CONTRACTS. The Company has no lease, contract or
commitment of any nature involving consideration or other expenditure in excess
of $10,000.00, or involving performance over a period of more than six (6)
months, or which is otherwise individually material to the operations of the
Company, except as explicitly described in SCHEDULE 3.12(K) or in any other
Schedule.
(l) NO DEFAULT. The Company is not in default under any lease,
contract or commitment, nor has any event or omission occurred which through the
passage of time or the giving of notice, or both, would constitute a default
thereunder or cause the acceleration of any of the Company's obligations or
result in the creation of any Lien on any of the assets owned, used or occupied
by the Company. To the best of the Company's and the Shareholder's knowledge, no
third party is in default under any lease, contract or commitment to which the
Company is a party, nor has any event or omission occurred which, through the
passage of time or the giving of notice, or both, would constitute a default
thereunder or give rise to an automatic termination, or the right of
discretionary termination, thereof.
3.13 OFFICERS, DIRECTORS, AGENTS, ETC. Set forth on SCHEDULE 3.13 attached
hereto is a complete list of all officers (with office held), directors,
contractors and agents of the Company, and the compensation and all vacation and
other benefits they are entitled to receive from the Company.
3.14 LABOR MATTERS. Except as set forth on SCHEDULE 3.14, the Company is
not and has never been a party to: (a) any profit sharing, pension, retirement,
deferred compensation, bonus, stock option, stock purchase, retainer,
consulting, health, welfare or incentive plan or agreement or other employee
benefit plan, whether legally binding or not; or other employee benefit plan,
whether legally binding or not; or (b) any plan providing for "fringe benefits"
to its employees, including, but not limited to, vacation, disability, sick
leave, medical, hospitalization and life insurance and other insurance plans, or
related benefits; or (c) any employment agreement. To the best of the Company's
and the Shareholder's knowledge, no former employee of the Company has any claim
against the Company (whether under federal or state law, any employment
agreement or otherwise) on account of or for: (a) overtime pay; (b) wages or
salary for any period; (c) vacation, time-off or pay in lieu of vacation or
time-off; or (d) any violation of any statue, ordinance or regulation relating
to minimum wages or maximum hours of work. To the best of the Company's and the
Shareholder's knowledge, no person or party (including, but not limited to,
governmental agencies of any kind) has any claim or basis for any action or
proceeding against the Company arising out of any statute, ordinance or
regulation relating to discrimination in employment or to employment practices
or occupational safety and health standards.
16
<PAGE>
3.15 COMPLIANCE WITH LAWS AND ORDERS.
(a) COMPLIANCE. Except as set forth in SCHEDULE 3.15 (A), the
Company (including each and all of its operations, practices, properties,
contracts, agreements and assets) is in compliance with all applicable Laws and
Orders, including, without limitation, those applicable to discrimination in
employment, Medicare, insurance, patient brokering and referral, advertising,
occupational safety and health, trade practices, competition, pricing and
billing, zoning, building and sanitation, employment, retirement and labor
relations, product advertising and the Environmental Laws as hereinafter
defined. Except as set forth in SCHEDULE 3.15 (A), the Company has not received
notice of any violation or alleged violation of, and to the best of the
Company's and the Shareholder's knowledge, is subject to no Liability for past
or continuing violation of, any Laws or Orders. All reports and returns required
to be filed by the Company with any Government Entity have been filed, and were
accurate and complete when filed. Without limiting the generality of the
foregoing:
(i) The operation of the Company's business as it is now
conducted does not, nor does any condition existing at any of its facilities, in
any manner constitute a nuisance or other tortuous interference with the rights
of any person or persons in such a manner as to give rise to or constitute the
grounds for a suit, action, claim or demand by any such person or persons
seeking compensation or damages or seeking to restrain, enjoin or otherwise
prohibit any material aspect of the conduct of such business or materially
affect the manner in which it is now conducted.
(ii) The Company has made all required payments to its
unemployment compensation reserve accounts with the appropriate governmental
departments of the states where it is required to maintain such accounts, and
each of such accounts has a positive balance.
(iii) The Company has timely filed, in a complete and
correct manner, all requisite claims and other reports required to be filed in
connection with all state and federal Medicare and Medicaid programs due on or
before the date hereof. There are no claims, actions, payment reviews, or
appeals pending or to the best of the Company's and the Shareholder's knowledge,
threatened before any commission, board or agency, including, without
limitation, any intermediary or carrier, the Administrator of the Health Care
Financing Administration, the Florida Department of Health and Rehabilitative
Services, the Florida Board of Pharmacy or any other state or federal agency
with respect to any Medicare or Medicaid claims filed by the Company on or
before the Closing Date or program compliance matters, which would materially
adversely affect the Business, the Company or the consummation of the
transactions contemplated hereby. No validation review or program integrity
review related to the Company (other than normal, routine reviews) has been
conducted by any commission, board or agency in connection with the Medicare or
Medicaid program, and no such reviews are scheduled, pending or, to the best of
the Company's and the Shareholder's knowledge, threatened against or affecting
the Company or the consummation of the transactions contemplated hereby.
17
<PAGE>
(iv) Neither the Company nor any person or entity providing
services for the Company have engaged in any activities which are prohibited
under 42 U.S.C. (delta)1320a-7a or (delta)1320a-7b, or the regulations
promulgated thereunder, pursuant to such statutes or any other related state or
local statutes and regulations, including but not limited to the following: (a)
knowingly and willfully making or causing to be made a false statement or
representation of a material fact in any application for any benefit or payment;
(b) knowingly and willfully making or causing to be made any false statement or
representation of a material fact for use in determining rights to any benefit
or payment; (c) failing to disclose knowledge by a claimant of the occurrence of
any event affecting the initial or continued right to any benefit or payment on
its, his or her own behalf or on behalf of another, with intent to fraudulently
secure such benefit or payment; and (d) knowingly and willfully soliciting or
receiving any remuneration, kickback, bribe or rebate, directly or indirectly,
overtly or covertly, in cash or in kind, or offering to pay or receive such
remuneration in return for (x) referring an individual to a person for the
furnishing or arranging for the furnishing of any item or service for which
payment may be made in whole or in part by Medicare or Medicaid, or (y)
purchasing, leasing or ordering, or arranging for or recommending purchasing,
leasing or ordering, any medication, goods, facility, service or item for which
payment may be made in whole or in part by Medicare or Medicaid. No physician
(or his or her immediate family members) having a "financial relationship" with
Company, as that term is defined in 42 U.S.C. Section 1395nn, is in a position,
directly or indirectly, to refer patients or services to the Company, or any
such referral complies with the requirements of 42 U.S.C. Section 1395nn and the
regulations promulgated pursuant thereto.
(v) The Company has filed when due any and all material cost
reports and other documentation and reports, if any, required to be filed by
third-party payors and governmental agencies in compliance with applicable
contractual provisions and/or laws, regulations and rules.
(b) LICENSES AND PERMITS. The Company has all licenses, permits,
approvals, authorizations and consents of all Government Entities and all
certification organizations required for the conduct of the Business (as
presently conducted and subject to the approval of the SCC, as proposed to be
conducted) and operation of its facilities. All such licenses, permits,
approvals, authorizations and consents are described in SCHEDULE 3.15 (B), are
in full force and effect and will not be affected or made subject to loss,
limitation or any obligation to reapply as a result of the transactions
contemplated hereby. Except as set forth in SCHEDULE 3.15 (B), the Company
(including its Business, operations, properties and assets) is and has been in
compliance with all such permits and licenses, approvals, authorizations and
consents.
(c) ENVIRONMENTAL MATTERS. The applicable Laws relating to pollution
or protection of the environment, including Laws relating to emissions,
discharges, generation, storage, releases or threatened releases of pollutants,
contaminants, chemicals or industrial, toxic, hazardous or petroleum or
petroleum-based substances or wastes ("Waste") into the environment (including,
without limitation, ambient air, surface water, ground water, land surface or
subsurface strata) or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Waste
including, without limitation, the Clean Water Act, the Clean Air Act, the
Resource Conservation and Recovery Act, the Toxic Substances Control Act and the
Comprehensive Environmental Response Compensation Liability Act ("CERCLA"), as
amended, and their state and local counterparts are herein collectively referred
to as the "Environmental Laws". Without limiting the generality of the foregoing
provisions of this Section 3.15, the Company is in full compliance with all
limitations, restrictions, conditions, standards, prohibitions, requirements,
obligations, schedules and timetables contained in the Environmental Laws or
contained in any regulations, code, plan, order, decree, judgment, injunction,
notice or demand letter issued, entered, promulgated or approved thereunder.
Except as set forth in SCHEDULE 3.15 (C), there is no Litigation nor, to the
best of the Company's and the Shareholder's knowledge, any demand, claim,
hearing or notice of violation pending or threatened against the Company
relating in any way to the Environmental Laws or any Order issued, entered,
promulgated or approved thereunder. Except as set forth in SCHEDULE 3.15 (C),
there are no past or present (or, to the best of the Company's and the
Shareholder' knowledge, future) events, conditions, circumstances, activities,
practices, incidents, actions, omissions or plans which may interfere with or
prevent compliance or continued compliance with the Environmental Laws or with
any Order issued, entered, promulgated or approved thereunder, or which may give
rise to any liability, including, without limitation, liability under CERCLA or
similar state or local Laws, or otherwise form the basis of any Litigation,
hearing, notice of violation, study or investigation, based on or related to the
manufacture, processing, distribution, use, treatment, storage, disposal,
transport or handling, or the emission, discharge, release or threatened release
into the environment, of any Waste.
18
<PAGE>
3.16 BOOKS AND RECORDS. With respect to all material matters occurring
since the inception of the Company, the minute books and other records of the
Company contain complete and accurate records of all such material matters,
meetings and other corporate actions of its shareholders and board of directors.
3.17 TAX MATTERS.
(a) PROVISION FOR TAXES. The provision made for taxes on the Recent
Balance Sheet is and will be sufficient for the payment of all federal, state,
foreign, county, local and other income, ad valorem, excise, profits, franchise,
occupation, property, payroll, sales, use, gross receipts and other taxes (and
any interest and penalties) and assessments, whether or not disputed, at the
date of the Recent Balance Sheet and for all years and periods prior thereto.
Since the date of the Recent Balance Sheet, the Company has not incurred any
taxes other than taxes incurred in the ordinary course of business consistent in
type and amount with past practices of the Company.
(b) TAX RETURNS FILED. Except as set forth on SCHEDULE 3.17(b), all
federal, state, foreign, county, local and other tax returns required to be
filed by or on behalf of the Company have been timely filed and when filed were
true and correct in all material respects, and the taxes shown as due thereon
were paid or adequately accrued. True and complete copies of all tax returns or
reports filed by the Company for each of its three (3) most recent fiscal years
have been delivered to MIOA. The Company has duly withheld and paid all taxes
which it is required to withhold and pay relating to salaries and other
compensation heretofore paid to the employees of the Company.
(c) TAX AUDITS. The Company has not received from the Internal
Revenue Service or from the tax authorities of any state, county, local or other
jurisdiction any notice of underpayment of taxes or other deficiency which has
not been paid nor any objection to any return or report filed by the Company.
There are outstanding no agreements or waivers extending the statutory period of
limitations applicable to any tax return or report.
(d) OTHER. Except as set forth in SCHEDULE 3.17 (D), the Company has
not (i) filed any consent or agreement under Section 341(f) of the Internal
Revenue Code of 1986, as amended (the "Code"), (ii) applied for any tax ruling,
(iii) entered into a closing agreement with any taxing authority, (iv) filed an
election under Section 338(g) or Section 338(h)(10) of the Code (nor has a
deemed election under Section 338(e) of the Code occurred), (v) made any
payments, or been a party to an agreement (including this Agreement) that under
any circumstances could obligate it to make payments that will not be deductible
because of Section 280G of the Code, or (vi) been a party to any tax allocation
or tax sharing agreement. The Company is not a "United States real property
holding company" within the meaning of Section 897 of the Code.
3.18 REAL ESTATE. The Company owns no real estate and has not committed to
purchase any real estate. The Company has good and marketable title to each of
the leaseholds described in SCHEDULE 3.18 attached hereto, free and clear of all
mortgages, liens, encumbrances, leases, equities, claims, shares, easements,
rights-of-way, covenants, conditions and restrictions except as otherwise
described in the leasehold agreements. Except as stated on SCHEDULE 3.18, no
officer, director, shareholder or employee of the Company, or any spouse, child
or other relative thereof, owns directly or indirectly, in whole or in part, any
of the leaseholds described on SCHEDULE 3.18. Each of the leases described on
SCHEDULE 3.18 is a valid and binding obligation of the Company and enforceable
in accordance with its terms and conditions, and to the best knowledge and
belief of the Company and the Shareholder, each of the leases described on
SCHEDULE 3.18 is a valid and binding obligation of each of the other parties
thereto. Neither the Company nor, to the best knowledge of the Company and the
Shareholder, any other party to any such lease is in default with respect to any
material term or condition thereof, nor to the best knowledge of the Company and
the Shareholder, has any event occurred which through the passage of time or the
giving of notice, or both, would constitute a default thereunder, or would cause
the acceleration of any obligation of any party thereto or the creation of a
lien or encumbrance upon any of the assets of the Company. So far as the Company
and Shareholder are aware, the use and operation of the buildings, fixtures and
other improvements described in SCHEDULE 3.18 as presently conducted is not in
violation of any applicable building code, zoning ordinance or other law or
regulation.
20
<PAGE>
3.19 INSURANCE. Set forth in SCHEDULE 3.19 is a complete and accurate list
and description of all policies of fire, liability, product liability, workers
compensation, health and other forms of insurance presently in effect with
respect to the Business and properties of the Company, true and correct copies
of which have heretofore been delivered to MIOA. SCHEDULE 3.19 includes, without
limitation, the carrier, the description of coverage, the limits of coverage,
retention or deductible amounts, amount of annual premiums, date of expiration
and the date through which premiums have been paid with respect to each such
policy, and any pending claims in excess of $5,000.00. All such policies are
valid, outstanding and enforceable policies and provide insurance coverage for
the properties, assets and operations of the Company, of the kinds, in the
amounts and against the risks customarily maintained by organizations similarly
situated; and no such policy (nor any previous policy) provides for or is
subject to any currently enforceable retroactive rate or premium adjustment,
loss sharing arrangement or other actual or contingent liability arising wholly
or partially out of events arising prior to the date hereof. SCHEDULE 3.19
indicates each policy as to which (a) the coverage limit has been reached or (b)
the total incurred losses to date equal 75% or more of the coverage limit. No
notice of cancellation or termination has been received with respect to any such
policy, and neither the Company nor the Shareholder has knowledge of any act or
omission of the Company which could result in cancellation of any such policy
prior to its scheduled expiration date. The Company has not been refused any
insurance with respect to any aspect of the operations of the Business nor has
its coverage been limited by any insurance carrier to which it has applied for
insurance or with which it has carried insurance during the last three years.
The Company has duly and timely made all claims it has been entitled to make
under each policy of insurance. There is no claim by the Company pending under
any such policies as to which coverage has been questioned, denied or disputed
by the underwriters of such policies, and neither the Company nor the
Shareholder knows of any basis for denial of any claim under any such policy.
The Company has not received any written notice from or on behalf of any
insurance carrier issuing any such policy that insurance rates therefor will
hereafter be substantially increased (except to the extent that insurance rates
may be increased for all similarly situated risks) or that there will hereafter
be a cancellation or an increase in a deductible (or an increase in premiums in
order to maintain an existing deductible) or nonrenewal of any such policy. Such
policies are sufficient in all material respects for compliance by the Company
with all requirements of law and with the requirements of all material contracts
to which the Company is a party.
3.20 PERSONNEL. SCHEDULE 3.20 attached hereto contains accurate and
complete information as to names and rates of compensation (whether in the form
of salaries, bonuses, commissions or other supplemental compensation now or
hereafter payable) of all personnel of the Company, together with information as
to any contracts with any such personnel. The Company has no pension,
profit-sharing, bonus, incentive, insurance or other employee benefit plans
(including without limitation any such plans within the meaning of Section 3 (3)
of the Employee Retirement Income Security Act of 1974, as amended) in which any
employees of the Company participate, except as set forth on the SCHEDULE 3.20.
3.21 LITIGATION. Other than as set forth in SCHEDULE 3.21, the Company is
not a party to, the subject of, or threatened with any litigation nor to the
best knowledge of the Company and the Shareholder, is there any basis for any
litigation. The Company is not contemplating the institution of any litigation.
21
<PAGE>
3.22 OTHER LIABILITIES. To the best of the Company's and the Shareholder's
knowledge no claim of breach of contract, tort, product liability or other
claim, contingent or otherwise, has been asserted or threatened against the
Company nor is capable of being asserted by any employee, creditor, claimant or
other person against the Company. To the best of the Company's and the
Shareholder's knowledge, no state of facts exists or has existed, nor has any
event occurred, which could give rise to the assertion of any such claim by any
person.
3.23 CONSENTS. The execution, delivery and performance by the Shareholder
of this Agreement and the consummation by the Shareholder of the transactions
contemplated hereby do not require any consent that has not been received prior
to the date hereof.
3.24 JUDGMENTS. There are no outstanding judgments against the Company.
There are no open workers compensation claims against the Company, or to the
best of the Company's and the Shareholder's knowledge, any other obligation,
fact or circumstance which would give rise to any right of indemnification on
the part of any current or former shareholder, director, officer, employee or
agent of the Company, or any heir or personal representative thereof, against
the Company, or any successor to the businesses of the Company.
3.25 BROKERS. Except as previously disclosed in writing, neither the
Shareholder nor the Company have any liability or obligation to pay any fees or
commissions to any broker, finder, or agent with respect to the transactions
contemplated by this Agreement for which MIOA could become liable or obligated.
3.26 TRADE RIGHTS. SCHEDULE 3.26 lists all Trade Rights (as defined below)
in which the Company now has any interest, specifying whether such Trade Rights
are owned, controlled, used or held (under license or otherwise) by the Company,
and also indicating which of such Trade Rights are registered. All Trade Rights
shown as registered in SCHEDULE 3.26 have been properly registered, all pending
registrations and applications have been properly made and filed and all
annuity, maintenance, renewal and other fees relating to registrations or
applications are current. In order to conduct the business of the Company, as
such is currently being conducted or proposed to be conducted, the Company does
not require any Trade Rights that it does not already have. To the best of the
Company's and the Shareholder's knowledge, the Company is not infringing and has
not infringed any Trade Rights of another in the operation of the business of
Company, nor is any other person infringing the Trade Rights of the Company. The
Company has not granted any license or made any assignment of any Trade Right
listed on SCHEDULE 3.26, nor does the Company pay any royalties or other
consideration for the right to use any Trade Rights of others. There is no
Litigation pending or to the best of the Company's and the Shareholder's
knowledge, threatened to challenge the Company's right, title and interest with
respect to its continued use and right to preclude others from using any Trade
Rights of the Company. All Trade Rights of the Company are valid, enforceable
and in good standing, and there are no equitable defenses to enforcement based
on any act or omission of the Company. The consummation of the transactions
contemplated hereby will not alter or impair any Trade Rights owned or used by
the Company. As used herein, the term "Trade Rights" shall mean and include: (i)
all trademark rights, business identifiers, trade dress, service marks, trade
names and brand names, all registrations thereof and applications therefor and
all goodwill associated with the foregoing; (ii) all copyrights, copyright
registrations and copyright applications, and all other rights associated with
the foregoing and the underlying works of authorship; (iii) all patents and
patent applications, and all international proprietary rights associated
therewith; (iv) all contracts or agreements granting any right, title, license
or privilege under the intellectual property rights of any third party; (v) all
inventions, mask works and mask work registrations, know-how, discoveries,
improvements, designs, trade secrets, shop and royalty rights, employee
covenants and agreements respecting intellectual property and non-competition
and all other types of intellectual property; and (vi) all claims for
infringement or breach of any of the foregoing.
22
<PAGE>
3.27 BANK ACCOUNTS.27 BANK ACCOUNTS.27 BANK ACCOUNTS.27 BANK ACCOUNTS.27
BANK ACCOUNTS.27 BANK ACCOUNTS. SCHEDULE 3.27 sets forth the names and locations
of all banks, trust companies, savings and loan associations and other financial
institutions at which the Company maintains a safe deposit box, lock box or
checking, savings, custodial or other account of any nature, the type and number
of each such account and the signatories therefor, a description of any
compensating balance arrangements, and the names of all persons authorized to
draw thereon, make withdrawals therefrom or have access thereto.
3.28 DISCLOSURE. No representation or warranty by the Company and/or the
Shareholder in this Agreement, nor any statement, certificate, schedule,
document or exhibit hereto furnished or to be furnished by or on behalf of the
Company or Shareholder pursuant to this Agreement or in connection with
transactions contemplated hereby, contains or shall contain any untrue statement
of material fact or omits or shall omit a material fact necessary to make the
statements contained therein not misleading. All statements and information
contained in any certificate, instrument, disclosure schedule or document
delivered by or on behalf of the Company and/or Shareholder shall be deemed
representations and warranties by the Company and the Shareholder.
ARTICLE IV.
REPRESENTATIONS AND WARRANTIES OF MIOA
MIOA hereby makes the following representations and warranties to the
Shareholder, each of which MIOA represents to be true and correct on the date
hereof, shall remain true and correct to and including the Effective Date, shall
be unaffected by any investigation heretofore or hereafter made by the
Shareholder, or any knowledge of the Shareholder other than as specifically
disclosed in the disclosure schedules delivered to the Shareholder, and shall
survive the Closing of the transactions provided for herein until the end of
Formula Period 4. Notwithstanding anything herein to the contrary, if the
Shareholder, by written notice prior to the expiration of Formula Period 4,
advises MIOA of his question, dispute, debate, variance or contention relative
to any specific representation or warranty of MIOA such survival period shall be
extended until such time as the matter in question is resolved.
23
<PAGE>
4.1. MIOA SHARES. All of the MIOA Shares shall be validly issued to the
Shareholder, fully paid and non-assessable. MIOA shall deliver, good and
marketable title to the MIOA Shares, which shares shall be fully paid and
non-assessable and except as otherwise provided in this Agreement shall be free
and clear of all Liens (as defined in Section 3.10(a) above).
4.2. ORGANIZATION. MIOA is a corporation duly organized, validly existing
and in good standing under the laws of the State of Florida and is not required
to be qualified or licensed as a foreign corporation in any other jurisdiction.
MIOA has the full power and authority to own all its assets and to conduct its
business as and where its business is presently conducted.
4.3. AUTHORITY AND APPROVAL OF AGREEMENT.
(a) The execution and delivery of this Agreement by MIOA and the
performance of all MIOA's obligations hereunder have been duly authorized and
approved by all requisite corporate action on the part of MIOA pursuant to
applicable law. MIOA has the power and authority to execute and deliver this
Agreement and to perform all its obligations hereunder.
(b) This Agreement and each of the other documents, instruments
and agreements executed by MIOA in connection herewith constitute the valid and
legally binding agreements of MIOA, enforceable against MIOA in accordance with
their terms, except that: (i) enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws of general
application affecting the enforcement of the rights and remedies of creditors;
and (ii) the availability of equitable remedies as may be limited by equitable
principles.
4.4. NO VIOLATIONS. Neither the execution, delivery nor performance of
this Agreement or any other documents, instruments or agreements executed by
MIOA in connection herewith, nor the consummation of the transactions
contemplated hereby: (a) constitutes a violation of or default under (either
immediately, upon notice or upon lapse of time) the Articles of Incorporation or
Bylaws of MIOA, any provision of any contract to which MIOA or its assets may be
bound, any judgment to which MIOA is bound or any law applicable to MIOA; or (b)
result in the creation or imposition of any encumbrance upon, or give any third
person any interest in or right to, any or all of the MIOA Securities or any
other capital stock of MIOA or any of the assets of MIOA; or (c) result in the
loss or adverse modification of, or the imposition of any fine or penalty with
respect to, any license, permit or franchise granted or issued to, or otherwise
held by or for the use of, MIOA.
4.5. CONSENTS. The execution, delivery and performance by MIOA of this
Agreement and the consummation by MIOA of the transactions contemplated hereby
do not require any consent that has not been received prior to the date hereof.
24
<PAGE>
4.6. S.E.C. DOCUMENTS. MIOA has delivered or made available to the
Shareholder all required reports, schedules, forms, statements and other
documents filed or to be filed with the Securities and Exchange Commission (the
"SEC") since January 1, 1996 (collectively, the "SEC DOCUMENTS"). The financial
statements included in the SEC Documents comply as to form in all material
respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto, have been prepared in accordance
with generally accepted accounting principles (except, in the case of the
unaudited statements, as permitted by Form 10-Q of the SEC) applied on a
consistent basis during the periods involved (except as may be indicated therein
or in the notes thereto).
4.7. ABSENCE OF CERTAIN CHANGES OR EVENTS. Except as disclosed in the SEC
Documents, since the date of the most recent financial statements included in
the SEC Documents, MIOA has conducted its business only in the ordinary course
consistent with past practice in light of its current business circumstances,
and there is not and has not been: (a) any material adverse change with respect
to MIOA or its capital stock; (b) any condition, event or occurrence which,
individually or in the aggregate, could reasonably be expected to have a
material adverse effect or give rise to a material adverse change with respect
to MIOA or its capital stock; or (c) any condition, event or occurrence which
could reasonably be expected to prevent, hinder or materially delay the ability
of MIOA to consummate the transactions contemplated by this Agreement.
4.8. BROKERS. MIOA has no liability or obligation to pay any fees or
commissions to any broker, finder, or agent with respect to the transactions
contemplated by this Agreement for which the Shareholder or the Company could
become liable or obligated.
4.9. FULL DISCLOSURE. To the best knowledge of MIOA, no representation or
warranty by MIOA in this Agreement, nor any statement, certificate, schedule,
document or exhibit hereto furnished or to be furnished by or on behalf of MIOA
pursuant to this Agreement or in connection with transactions contemplated
hereby, contains or shall contain any untrue statement of material fact or omits
or shall omit a material fact necessary to make the statements contained therein
not materially misleading.
4.10. NO ENCUMBRANCES ON MIOA SECURITIES. Except as set forth in this
Agreement, the MIOA Shares being transferred by MIOA to the Shareholder and his
assigns are free and clear of any liens, claims, encumbrances or restrictions of
any kind, and none of those shares is subject to options, rights, warrants, or
other agreements or commitments other than set forth in this Agreement.
25
<PAGE>
ARTICLE V.
INTERPRETATION; SURVIVAL OF
REPRESENTATIONS AND WARRANTIES; AND INDEMNIFICATION
5.1. INTERPRETATION. Except where indicated otherwise, each warranty and
representation made by a party in this Agreement or pursuant hereto is
independent of all other warranties and representations made by the same party
in this Agreement or pursuant hereto (whether or not covering identical, related
or similar matters) and must be independently and separately satisfied. Except
where indicated otherwise, exceptions or qualifications to any such warranty or
representation shall not be construed as exceptions or qualification to any
other warranty or representation.
5.2. SURVIVAL. All representations and warranties made in this Agreement
or pursuant hereto shall survive the date hereof and the Effective Date through
Formula Period 4. Notwithstanding anything herein to the contrary, if an
indemnitee under this agreement, by written notice prior to the expiration of
Formula Period 4, advises an indemnitor of its question, dispute, debate,
variance or contention relative to any specific representation warranty or other
matter which is subject to the indemnity provisions of this Section, such
survival period shall be extended until such time as the matter in question is
resolved.
5.3. INDEMNIFICATION.
(a) BY SHAREHOLDER. The Shareholder hereby agrees to indemnify,
defend and hold harmless MIOA, its subsidiaries and their directors, officers,
employees and controlled and controlling persons (hereinafter "MIOA'S
AFFILIATES"), from and against all Claims (as hereinafter defined) asserted
against, resulting to, imposed upon, or incurred by MIOA, MIOA's affiliates, the
Company, their businesses or their assets, directly or indirectly, by reason of,
arising out of or resulting from (x) the inaccuracy or breach of any
representation or warranty of the Company or such Shareholder contained in or
made pursuant to Article III of this Agreement; (y) the breach of any covenant
of the Company or such Shareholder contained in this Agreement, and (z) any
Claim against the Company, its business or its assets not otherwise disclosed in
this Agreement or the disclosure schedules relating to or arising from matters
related to or arising from the Company, or its businesses prior to the Effective
Date. As used in this section, the term "CLAIM" shall include (i) all
liabilities; (ii) all losses, damages, judgments, awards, settlements, costs and
expenses (including, without limitation, interest including prejudgment interest
in any litigated matter), penalties, court costs and attorneys fees and
expenses); and (iii) all demands, claims, actions, costs of investigation,
causes of action, proceedings and assessments ultimately determined to be valid.
For purposes of this Section the representations, warranties and covenants set
forth in this Agreement shall be read as if the qualifying terms "best
information, knowledge and/or belief" were not set forth therein.
(b) BY MIOA. MIOA hereby agrees to indemnify, defend and hold
harmless Shareholder from and against all Claims asserted against, resulting to,
imposed upon or incurred by any such person, directly or indirectly, by reason
of or resulting from (x) the inaccuracy or breach of any representation or
warranty of MIOA contained in or made pursuant to this Agreement; (y) the breach
of any covenant of MIOA contained in this Agreement; or (z) all Claims of or
against Shareholder specifically assumed by MIOA pursuant hereto.
26
<PAGE>
(c) MATERIALITY. The parties recognize that many of the
representations, warranties and covenants set forth in this Agreement are
qualified by the term "MATERIAL". For purposes of this Agreement, the parties
hereby agree that a "MATERIAL" event(s) has occurred if the impact of such
event(s) has resulted or is reasonably likely to result in costs, expenses
and/or damages for any event(s) singularly or in the aggregate in excess of
Fifty Thousand Dollars ($50,000.00)
5.4. LIMITATION.
(A) GENERAL. The parties agree that the indemnification provisions
set forth in this Article shall be limited to all Claims in excess of Fifty
Thousand Dollars ($50,000.00) (the "Threshold"). Once a Claim exceeds the
Threshold, if a party is entitled to indemnification under Section 5.3, such
party shall recover all appropriate funds, as provided in Section 5.3, with no
reduction for the Threshold amount. Further, the indemnitors shall not be liable
for any liabilities resulting from Claims that are covered by any insurance
policy or other indemnity or contribution agreement unless, and only to the
extent that, the full limit of such insurance policy, indemnity or contribution
agreement has been exceeded.
(B) SHAREHOLDER LIMITS. Notwithstanding anything herein to the
contrary, in no event shall the Shareholder be liable for more than the "fair
market value" of the MIOA Shares, the Earn-up Options and the consideration paid
pursuant to the Put Option in Section 2.1(a)(iv) ("Put Consideration") which, at
the time of the payment of the Claim to the indemnitee, the Shareholder has
received or shall be entitled to receive pursuant to this Agreement, less the
pre-tax earnings of the Company for the period beginning on the Effective Date
and ending on the date the indemnitee is obligated to pay such Claim. At the
option of the Shareholder, any payment made pursuant to Section 5.3 may be made
in either clear and immediately available funds or by surrendering an
appropriate number of MIOA Shares, the Earn-up Options and/or the Put
Consideration or the rights to receive same. The number of MIOA Shares to be
surrendered to MIOA shall be calculated by dividing the amount of any Claim, as
set forth in writing by MIOA and supported by reasonable documentation, by the
fair market value of the MIOA Shares as of the date the indemnitee is obligated
to pay such Claim. In respect to the Earn-up Options, the parties shall use
their best efforts to fairly value the Earn-up Options. To the extent that the
parties can not agree on the value of such options then, in such event, the
Shareholder and MIOA shall each select an appraiser to value the Earn-up
Options. If the appraisers can not agree as the value then, in such event, the
appraisers shall select a third appraiser whose valuation shall be binding upon
the parties. If all MIOA Shares, Earn-up Options, the Put Consideration and the
rights to receive same are returned to MIOA as payment of any amount due or
claimed under Section 5.3, then such surrender shall be deemed full and complete
payment of all amounts due and that can be claimed in the future under Section
5.3. For purposes of this Section the term "FAIR MARKET VALUE" of a MIOA Share
shall be calculated as of the date the indemnitee is obligated to pay such Claim
and shall be determined as follows: (1) if the principal market for such stock
is a national securities exchange, the average of the highest and lowest sales
prices per share of such stock on such day as reported by such exchange or on a
composite tape reflecting transactions on such exchange, (2) if the principal
market for such stock is not a national securities exchange and such stock is
quoted on The Nasdaq Stock Market ("NASDAQ"), and (i) if actual sales price
information is available with respect to such stock, the average of the highest
and lowest sales prices per share of such stock on such day on Nasdaq, or (ii)
if such information is not available, the average of the highest bid and lowest
asked prices per share of such stock on such day on Nasdaq, or (3) if the
principal market for such stock is not a national securities exchange and such
stock is not quoted on Nasdaq, the average of the highest bid and lowest asked
prices per share of such stock on such day as reported on the OTC Bulletin Board
Service or by National Quotation Bureau, Incorporated or a comparable service;
PROVIDED, HOWEVER, that if clauses (1), (2) and (3) of this Section are all
inapplicable, or if no trades have been made or no quotes are available for such
day, the fair market value of such stock shall be determined by appraisal as set
forth above.
27
<PAGE>
(C) MIOA LIMITS. Notwithstanding anything herein to the contrary, in
no event shall MIOA be liable for more than the Company's gross revenues for the
fiscal year ending December 31, 1998.
ARTICLE VI.
OTHER COVENANTS
6.1. NON-COMPETITION; CONFIDENTIALITY. Subject to the Closing, and as an
inducement to MIOA to execute this Agreement and complete the transactions
contemplated hereby, and in order to preserve the goodwill associated with the
business of the Company being acquired pursuant to this Agreement, and in
addition to and not in limitation of any covenants contained in any agreement
executed and delivered herewith, the Shareholder hereby covenants and agrees as
follows:
(a) COVENANT NOT TO COMPETE. The Shareholder agrees that for so long
as the Shareholder is employed by the Surviving Company, MIOA or any of its
subsidiaries and for a continuous and uninterrupted period of two (2) years
thereafter, if terminated "For Cause" as that term is defined in the
Shareholder's employment contract of even date herewith:
(1) engage in, continue in or carry on any business which
competes with the Business or is substantially similar thereto, including owning
or controlling any financial interest in any corporation, partnership, firm or
other form of business organization which is so engaged;
(2) consult with, advise or assist in any way, whether or not
for consideration, any corporation, partnership, firm or other business
organization which is now or becomes a competitor of the Surviving Corporation,
MIOA or MIOA's subsidiaries in any aspect with respect to the Business,
including, but not limited to, advertising or otherwise endorsing the products
of any such competitor; soliciting customers or otherwise serving as an
intermediary for any such competitor; loaning money or rendering any other form
of financial assistance to or engaging in any form of business transaction on
other than an arm's length basis with any such competitor;
28
<PAGE>
(3) offer employment to an employee of the Surviving
Corporation, MIOA or MIOA's subsidiaries, without the prior written consent of
MIOA; or
(4) engage in any practice the purpose of which is to evade
the provisions of this covenant not to compete or to commit any act which
adversely affects the Surviving Corporation, MIOA, MIOA's subsidiaries or their
businesses;
provided, however, that the foregoing shall not prohibit the
Shareholder from working for them or the ownership of securities of corporations
which are listed on a national securities exchange or traded in the national
over-the-counter market in an amount which shall not exceed 5% of the
outstanding shares of any such corporation. The parties agree that the
geographic scope of this covenant not to compete shall extend in an outward
radius of 15 miles from any clinic, lab, medical facility or any other business
of the Surviving Company, Ivanhoe or any similar business of any other
subsidiary of MIOA. The parties agree that MIOA may sell, assign or otherwise
transfer this covenant not to compete, in whole or in part, to any person,
corporation, firm or entity that purchases all or substantially all of the
business of the Surviving Company. In the event a court of competent
jurisdiction determines that the provisions of this covenant not to compete are
excessively broad as to duration, geographical scope or activity, it is
expressly agreed that this covenant not to compete shall be construed so that
the remaining provisions shall not be affected, but shall remain in full force
and effect, and any such over broad provisions shall be deemed, without further
action on the part of any person, to be modified, amended and/or limited, but
only to the extent necessary to render the same valid and enforceable in such
jurisdiction.
(b) COVENANT OF CONFIDENTIALITY. The Shareholder shall not at any
time subsequent to the Closing, except as explicitly requested by MIOA, (i) use
for any purpose, (ii) disclose to any person, or (iii) keep or make copies of
documents, tapes, discs or programs containing, any confidential information
concerning the Business or the Surviving Company. For purposes hereof,
"CONFIDENTIAL INFORMATION" shall mean and include, without limitation, all Trade
Rights in which the Surviving Company or has an interest, all customer lists and
customer information, and all other information concerning the Surviving
Company's processes, apparatus, equipment, packaging, services, products,
marketing and other business methods, not previously disclosed to the public
directly by the Surviving Company.
(c) EQUITABLE RELIEF FOR VIOLATIONS. The Shareholder agrees that the
provisions and restrictions contained in this Section 6.1 are necessary to
protect the legitimate continuing interests of MIOA, and that any violation or
breach of these provisions will result in irreparable injury to MIOA for which a
remedy at law would be inadequate and that, in addition to any relief at law
which may be available to MIOA for such violation or breach and regardless of
any other provision contained in this Agreement, MIOA shall be entitled to
injunctive and other equitable relief as a court may grant after considering the
intent of this Section 6.1.
29
<PAGE>
6.2. GENERAL RELEASES. At the Closing, the Shareholder shall deliver
general releases to MIOA, substantially in the form attached hereto as EXHIBIT
__, releasing the Surviving Company and its directors, officers, agents and
employees of the Surviving Company from all claims through the Effective Date,
except (i) as may be described in written contracts disclosed in the disclosure
schedules and expressly described and excepted from such releases, and (ii)
indemnification rights and compensation for current periods expressly described
and excepted from such releases. Such releases shall also contain waivers of any
right of contribution or other recourse against the Surviving Company with
respect to representations, warranties or covenants made herein by the Company.
6.3. ACCESS TO INFORMATION AND RECORDS. During the period prior to the
Effective Date, the Shareholder shall cause the Company to give MIOA, its
counsel, accountants and other representatives (i) access during normal business
hours to all of the properties, books, records, contracts and documents of the
Company and for the purpose of such inspection, investigation and testing as
MIOA deems appropriate (and the Company shall furnish or cause to be furnished
to MIOA and its representatives all information with respect to the business and
affairs of the Company as MIOA may request); (ii) access to employees, agents
and representatives for the purposes of such meetings and communications as MIOA
reasonably desires; and (iii) with the prior consent of the Company in each
instance (which consent shall not be unreasonably withheld), access to vendors,
customers, manufacturers of its machinery and equipment, and others having
business dealings with the Company.
6.4. CONDUCT OF BUSINESS PENDING THE EFFECTIVE DATE. From the date hereof
until the Effective Date, except as otherwise approved in writing by MIOA, the
Company and the Shareholder covenant as follows:
(a) NO CHANGES. The Company will carry on its business diligently
and in the same manner as heretofore and will not make or institute any changes
in its methods of purchase, sale, management, accounting or operation.
(b) MAINTAIN ORGANIZATION. The Company and the Shareholder will take
such action as may be necessary to maintain, preserve, renew and keep in favor
and effect the existence, rights and franchises of the Company and they will use
their best efforts to preserve the business organization of the Company intact,
to keep available to the Company the present officers and employees, and to
preserve for the Company their present relationships with suppliers and
customers and others having business relationships with the Company.
(c) NO BREACH. Neither the Company nor the Shareholder will not do
or omit any act, or permit any omission to act, which may cause a breach of any
material contract, commitment or obligation, or any breach of any
representation, warranty, covenant or agreement made by the Company and the
Shareholder herein, which would have required disclosure herein had it occurred
after the date of the Recent Balance Sheet and prior to the date of this
Agreement.
30
<PAGE>
(d) NO MATERIAL CONTRACTS. No contract or commitment will be entered
into, and no purchase of equipment, parts or supplies and no sale of goods or
services (real, personal, or mixed, tangible or intangible) will be made, by or
on behalf of Company, except contracts, commitments, purchases or sales which
are in the ordinary course of business and consistent with past practice, are
not material to the Company (individually or in the aggregate) and would not
have been required to be disclosed in the disclosure schedules had they been in
existence on the date of this Agreement.
(e) NO CORPORATE CHANGES. Except as otherwise provided herein, the
Company shall not amend its Articles of Incorporation or Bylaws or make any
changes in authorized or issued capital stock.
(f) MAINTENANCE OF INSURANCE. The Company shall maintain all of the
insurance in effect as of the date hereof and shall procure such additional
insurance as shall be reasonably requested by MIOA.
(g) MAINTENANCE OF PROPERTY. The Company and the Shareholder shall
use, operate, maintain and repair all the Company's property in a normal
business manner.
(h) INTERIM FINANCIALS. The Company will provide MIOA with interim
monthly financial statements and other management reports as and when they are
available.
(i) NO NEGOTIATIONS. Neither the Company nor the Shareholder will
directly or indirectly (through a representative or otherwise) solicit or
furnish any information to any prospective buyer, commence, or conduct presently
ongoing, negotiations with any other party or enter into any agreement with any
other party concerning the sale of the Company, the Company's assets or business
or any part thereof or any equity securities of the Company (an "ACQUISITION
PROPOSAL"), and the Company and the Shareholder shall immediately advise MIOA of
the receipt of any acquisition proposal.
(j) NO TRANSFER OF SHARES. The Shareholder shall not transfer or
attempt to transfer any of the Klein Shares except as provided herein; and the
Company shall refuse to accept any certificates for the Klein Shares to be
transferred or otherwise to allow such transfers to occur upon its books.
6.5. CONSENTS. MIOA, the Company and the Shareholder will use their best
efforts prior to the Effective Date to obtain all consents necessary for the
consummation of the transactions contemplated hereby.
31
<PAGE>
6.6. OTHER ACTION. MIOA, the Company and the Shareholder shall use their
best efforts to cause the fulfillment at the earliest practicable date of all of
the conditions to the parties' obligations to consummate the transactions
contemplated in this Agreement.
6.7. DISCLOSURE SCHEDULE. MIOA, the Shareholder and the Company shall have
a continuing obligation to promptly notify each other in writing with respect to
any matter hereafter arising or discovered which, if existing or known at the
date of this Agreement, would have been required to be set forth or described in
the disclosure schedules, but no such disclosure shall cure any breach of any
representation or warranty which is inaccurate.
ARTICLE VII.
CONDITIONS PRECEDENT TO THE SHAREHOLDER'S OBLIGATIONS
Notwithstanding the execution and delivery of this Agreement or the
performance of any part hereof, the Shareholder's obligation to consummate the
transaction contemplated by this Agreement shall be subject to the satisfaction
of each of the conditions set forth in this Article VII, except to the extent
that such satisfaction is waived in writing by the Shareholder.
7.1. REPRESENTATIONS AND WARRANTIES OF MIOA. All representations and
warranties made by MIOA in this Agreement and the Schedules hereto shall be true
and correct in all material respects on the date hereof, and shall be true and
correct in all material respects at the time of the Effective Date as though
such representations were again made, without exception or deviation, at the
time of the Effective Date.
7.2. PERFORMANCE OF THIS AGREEMENT. MIOA shall have duly performed or
complied with all the obligations under this Agreement to be performed or
complied with by MIOA on or prior to the Effective Date.
7.3. ABSENCE OF LITIGATION. No litigation shall have been instituted on or
before the time of the Effective Date by any person, the result of which did or
could prevent or make illegal the consummation of the transaction contemplated
by this Agreement, or which had or could have a material adverse effect on MIOA.
7.4. SHAREHOLDER GUARANTEES. MIOA shall use all reasonable efforts to have
the Shareholder removed from any and all guarantees, agreements, obligations or
debts, as identified in SCHEDULE 7.4, that were entered into by the Shareholder
to facilitate or induce another party to engage in any business activity with
the Company. If MIOA is unable to remove the Shareholder from such guarantees,
agreements, obligations or debts then, in such event, MIOA will indemnify the
Shareholder for any damages the Shareholder incurs relative to such guarantees,
agreements, obligations or debts.
7.5. DELIVERIES AT CLOSING. On or prior to the Effective Date, in addition
to all other deliveries to be made by MIOA, MIOA shall deliver or cause to be
delivered to the Shareholder a certificate signed by an officer of MIOA, dated
the Effective Date, certifying that: (a) all of the terms and conditions of this
Agreement to be satisfied or performed by MIOA on or before the time of the
Effective Date have been satisfied or performed; and (b) no litigation has been
instituted or, or to best of said officer's knowledge threatened on or before
the time of the Effective Date by any person, the result of which did or could
prevent or make illegal the consummation of the transaction contemplated by this
Agreement.
32
<PAGE>
ARTICLE VIII.
CONDITIONS PRECEDENT TO MIOA OBLIGATIONS
Notwithstanding the execution and delivery of this Agreement or the
performance of any part hereof, MIOA's obligations to consummate the transaction
contemplated by this Agreement shall be subject to the satisfaction of each of
the conditions set forth in this Article VIII, except to the extent that such
satisfaction is waived by MIOA in writing.
8.1. REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDER. All
representations and warranties made by the Company and the Shareholder contained
in this Agreement and the disclosure schedules hereto shall be true and correct
in all material respects on the date hereof, and shall be true and correct in
all material respects at the time of the Effective Date as though such
representations were again made, without exception or deviation, at the time of
the Effective Date.
8.2. PERFORMANCE OF THIS AGREEMENT. The Company and the Shareholder shall
have duly performed or complied with all of the covenants and obligations under
this Agreement to be performed or complied with by them on or prior to the
Effective Date.
8.3. ABSENCE OF LITIGATION. No litigation shall have been instituted on or
before the time of the Effective Date by any person, the result of which did or
could prevent or make illegal the consummation of the transaction contemplated
by the Agreement, or which had or could have a material adverse effect on the
Company or its Business.
8.4. DELIVERIES AT CLOSING. On or prior to the Effective Date, in addition
to all other deliveries to be made by the Shareholder hereunder, the Shareholder
shall deliver or cause to be delivered a certificate signed by the Shareholder,
dated as of the Effective Date, certifying that: (a) all of the terms and
conditions of this Agreement to be satisfied or performed by the Company and the
Shareholder on or before the time of the Effective Date have been satisfied or
performed; (b) no litigation has been instituted or, to the best of their
knowledge, threatened on or before the time of the Effective Date by any person,
the result of which did or could prevent or make illegal the consummation of the
transaction contemplated by this Agreement; or which had or could have a
material adverse effect on the Company or its Business; and (c) there has not
been any material adverse change in or affecting the Company or its Business
between the date of this Agreement and the Effective Date.
8.5. COMPLETION OF DUE DILIGENCE, BUSINESS PLAN, SCHEDULES & EXHIBITS. It
is hereby acknowledged that as of the Closing Date of this Agreement, the
parties to this Agreement have not completed all the Schedules, Exhibits,
Company leases and employment agreements and other ancillary documents.
Accordingly, both the Shareholder's and MIOA's obligation to consummate the
transactions contemplated by this Agreement shall be subject to completion and
execution, where necessary, of all the Schedules, Exhibits, Company leases and
employment agreements and other ancillary documents all to their reasonable
satisfaction. Subject to Article 10 hereafter, if the parties do not complete
all the Schedules, Exhibits, Company leases and employment agreements and other
ancillary documents or if either party is not reasonably satisfied as to all
such matters by August 30, 1998, then this Agreement and all other collateral
documents executed in connection with the transactions contemplated by this
Agreement may be terminated by either MIOA or the Shareholder.
33
<PAGE>
ARTICLE IX.
OBLIGATIONS ON OR BEFORE THE EFFECTIVE DATE
9.1. OBLIGATIONS OF MIOA TO THE SHAREHOLDER ON OR BEFORE THE EFFECTIVE
DATE. MIOA hereby covenants and agrees to deliver or cause to be delivered to
the Shareholder on or before the Effective Date or, if agreed, as soon
thereafter as is reasonably possible the following:
(a) Duly issued certificates (legend as provided in Section 2.2 (a)
hereof) representing the Initial Payment, together with any documentary stamps
required in connection with such transfer and such other appropriate documents
and instruments of transfer as the Shareholder may reasonably request;
(b) A certification by an officer of MIOA that MIOA was authorized
to execute, deliver and perform this Agreement and is authorized to consummate
the transactions contemplated hereby; and
(c) All Schedules, Exhibits, Company leases and employment
agreements and other ancillary documents contemplated by this Agreement and such
other documents and instruments as the Shareholder may reasonably request in
order to effectuate the terms of this Agreement.
9.2. OBLIGATIONS OF THE COMPANY AND THE SHAREHOLDER TO MIOA ON OR BEFORE
THE EFFECTIVE DATE. The Company and the Shareholder hereby covenant and agree to
deliver or cause to be delivered to MIOA on or before the Effective Date or, if
agreed, as soon thereafter as is reasonably possible the following:
(a) Duly executed stock certificates representing the Klein Shares,
free and clear of all encumbrances together with any documentary stamps required
in connection with such transfer and such other appropriate documents and
instruments of transfer as MIOA may reasonably request ;
34
<PAGE>
(b) A certification by the Company's president that the Company was
authorized to execute, deliver and perform this Agreement and is authorized to
consummate the transactions contemplated hereby;
(c) A Good Standing Certificate for the Company from the State of
Virginia dated no later than the Effective Date.
(d) Incumbency certificates relating to each person executing (as a
corporate officer or otherwise on behalf of another person) any document
executed and delivered to MIOA pursuant to the terms hereof.
(e) The General Releases referred to in Section 6.2, duly executed
by the persons referred to in such Section.
(f) All Schedules, Exhibits, Company leases and employment
agreements and other ancillary documents contemplated by this Agreement and such
other documents and instruments as MIOA may reasonably request in order to
effectuate the terms of this Agreement.
(g) An estoppel certificate or status letter from each of the
landlords in respect to the real estate leases of the Company which shall
certify that (i) the lease is valid and in full force and effect; (ii) the
amounts payable by the Company under the lease and the date to which the same
have been paid; (iii) whether there are, to the knowledge of said landlord, any
defaults thereunder, and, if so, specifying the nature thereof; and (iv) that
the transactions contemplated by this Agreement will not constitute default
under the lease.
ARTICLE X.
TERMINATION AND RECISSION
10.1. TERMINATION PRIOR TO EFFECTIVE DATE. If, prior to the Effective
Date:
(a) A party hereto shall materially breach or default in the full
and timely performance and satisfaction of any of its representations and
warranties or obligations under this Agreement, and such breach or default is
not cured on or before the fifth (5th) day (or such reasonably longer period if
five (5) days is an unreasonable period to cure such breach or default) after
the date notice is given by the non-defaulting party to the defaulting party
specifying the nature of such breach or default, then the non-defaulting party
may terminate this Agreement at anytime following the period for curing such
breach or default. The Effective Date will be extended for such reasonable
period necessary to allow the defaulting party to cure the breach or default.
(b) If any of the conditions set forth in Article VII hereof are not
satisfied at or before the time of the Effective Date, then the Company and/or
the Shareholder may terminate this Agreement by notifying MIOA prior to the
Effective Date. The Effective Date will be extended for such reasonable period
necessary to allow for the satisfaction of such conditions; provided that such
extension shall not be beyond August 30, 1998.
35
<PAGE>
(c) If any of the conditions set forth in Article VIII hereof are
not satisfied at or before the time of the Effective Date, then MIOA may
terminate this Agreement by notifying the Company and the Shareholder prior to
the Effective Date. The Effective Date will be extended for such reasonable
period necessary to allow for the satisfaction of such conditions; provided that
such extension shall not be beyond August 30, 1998.
10.2. RECISSION POST EFFECTIVE DATE. Due to the material nature of this
transaction, the Company is required to undergo an audit by independent
certified public accountants ("CPA's"). If, for whatever reason, the Company's
CPA's are unable to render an unqualified opinion in accordance with GAAP or if
during the course of the audit a matter is revealed or discovered which could,
in the opinion of MIOA, have a material adverse affect on MIOA or the Company
then, in such event, MIOA shall have the right to rescind this transaction by
providing written notice to the Shareholder. Such notice must be given no later
than September 30, 1998. If the transaction is rescinded in accordance with this
provision, MIOA shall transfer all the stock, or the assets and liabilities, of
the Surviving Corporation to Shareholder in exchange for any and all
consideration paid to the Shareholder in connection with this Agreement.
Thereafter, all rights, duties and obligations of the parties shall terminate
and this Agreement shall be null and void with no further force or effect.
ARTICLE XI.
MISCELLANEOUS
11.1. NOTICES. All notices, requests, demands and other communications
hereunder shall be deemed to have been duly given if the same shall be in
writing and shall be delivered personally or sent by registered or certified
mail, postage prepaid, and addressed as set forth below:
If to the Shareholder: David S. Klein, M.D.
13 W. Beverley Street
Masonic Lodge, 2nd floor
Staunton, VA 24401
With a copy to: Angela Vanleer Whitesell, Esq.
23 N. Augusta Street
Staunton, VA 24401
To Company: David S. Klein, M.D., P.C.
13 W. Beverley Street
Masonic Lodge, 2nd floor
Staunton, VA 24401
If to MIOA: Medical Industries of America, Inc.
1903 S. Congress Ave., #400
Boynton Beach, FL 33463
Attn: Paul C. Pershes, President
36
<PAGE>
Any such notices shall be deemed received upon actual receipt if
personally delivered or the third business day after the post-marked date of
mailing.
11.2. ENTIRE AGREEMENT. This Agreement, including the disclosure schedules
attached hereto and the documents delivered pursuant hereto, sets forth all the
promises, covenants, agreements, conditions and understandings among the parties
hereto with respect to the subject matter hereof, and supersedes all prior and
contemporaneous agreements, understandings, inducements or conditions, expressed
or implied, oral or written, except as herein contained. No changes of or
modifications or additions to this Agreement shall be valid unless same shall be
in writing and signed by the parties hereto.
11.3. BINDING EFFECT; ASSIGNMENT. This Agreement shall be binding upon the
parties hereto, their beneficiaries, heirs and administrators. No party may
assign or transfer its interests herein, or delegate its duties hereunder,
without the written consent of the other parties.
11.4. AMENDMENT. The parties hereby irrevocably agree that no attempted
amendment, modification or change (collectively, "AMENDMENT") of this Agreement
shall be valid and effective, unless the parties shall unanimously agree in
writing to such Amendment.
11.5. NO WAIVER. No waiver of any provision of this Agreement shall be
effective unless it is in writing and signed by the party against whom it is
asserted, and any such written waiver shall only be applicable to the specific
instance to which it relates and shall not be deemed to be a continuing or
future waiver.
11.6. GENDER AND USE OF SINGULAR AND PLURAL. All pronouns shall be deemed
to refer to the masculine, feminine, neuter, singular or plural, as the identity
of the party or parties or their personal representatives, successors and
assigns may require.
11.7. COUNTERPARTS. This Agreement and any amendments may be executed in
one or more counterparts, each of which shall be deemed an original and all of
which together shall constitute one and the same instrument.
11.8. HEADINGS. The article and section headings contained in this
Agreement are inserted for convenience only and shall not affect in any way the
meaning or interpretation of the Agreement.
37
<PAGE>
11.9. GOVERNING LAW. This Agreement shall be construed in accordance with
the laws of the State of Virginia, and any litigation pertaining or related to
this Agreement shall, to the extent permitted by law, be held in the courts of
the State of Virginia.
11.10. FURTHER ASSURANCES. The parties hereto shall execute and deliver
such further instruments and do such further acts and things as may be
reasonably required to carry out the intent and purposes of this Agreement.
11.4 41. LITIGATION. If any party hereto is required to engage in
litigation or arbitration against any other party hereto, either as plaintiff or
as defendant, in order to enforce or defend any of its or his rights under this
Agreement, and such litigation results in a final judgment in favor of such
party (the "PREVAILING PARTY"), then the party or parties against whom said
final judgment is obtained shall reimburse the Prevailing Party for all direct,
indirect or incidental expenses incurred by the Prevailing Party in so enforcing
or defending its or his rights hereunder, including, but not limited to, all
attorneys' fees, paralegal' fees, court costs and other expenses incurred
throughout all negotiations, trials or appeals undertaken in order to enforce
the Prevailing Party's rights hereunder.
11.12. CONFIDENTIALITY. Except for discussions of the transactions
contemplated by this Agreement among the parties hereto and their
representatives and counsel participating in this transaction, and except as may
be required of the Corporation pursuant to federal securities laws, each party
hereto shall, unless all other parties hereto shall otherwise agree, keep
confidential and not, directly or indirectly, disclose to any person the
existence of this Agreement, the transaction contemplated by this Agreement or
any of the terms thereof, and each party hereto shall use its good faith efforts
to cause its employees, agents, officers, directors and representatives to abide
by the foregoing restrictions on disclosure.
11.13. COSTS AND EXPENSES. The parties hereby agree that they each will be
responsible for the payment of their respective costs and expenses including
professional fees incurred in connection with this transaction with the further
understanding that fifty percent (50%) of such costs and expenses incurred by
the Company shall be the responsibility of the Shareholder.
[SIGNATURES ON THE NEXT PAGE]
38
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be executed as of the date and year set forth above.
WITNESSES: MEDICAL INDUSTRIES OF AMERICA, INC.
By: /s/ PAUL C. PERSHES
Print name: Paul C. Pershes, President
MIOA ACQUISTION COMPANY V, INC.
By: /s/ PAUL C. PERSHES
Print name: Paul C. Pershes, President
SHAREHOLDER:
/s/ DAVID S. KLEIN
Print name: David S. Klein, M.D.
DAVID S. KLEIN, M.D., P.C.
By: /s/ DAVID S. KLEIN
Print name: David S. Klein, President
39
<PAGE>
EXHIBIT A
ARTICLES OF MERGER
40
<PAGE>
EXHIBIT B
ARTICLES OF INCORPORATION
41
<PAGE>
EXHIBIT C
BYLAWS
42
<PAGE>
EXHIBIT D
SHAREHOLDERS AGREEMENT
43
<PAGE>
EXHIBIT E
MIOA STOCK CERTIFICATE LEGENDS
44
<PAGE>
EXHIBIT F
GENERAL RELEASES
45
EXHIBIT 2.1
EMPLOYMENT AGREEMENT
BY AND BETWEEN
DAVID S. KLEIN, M.D., P.C.,
MIOA ACQUISITION COMPANY V, INC.
AND
DAVID S. KLEIN, M.D.
THIS EMPLOYMENT AGREEMENT (the "Agreement") is executed by and
between David S. Klein, M.D., P.C., a Virginia professional corporation (the
"Company"), MIOA Acquisition Company, V, Inc. ("Acquisition Corp"), a wholly
owned subsidiary of Medical Industries of America, Inc. ("MIOA"),and David S.
Klein, M.D. ("Physician") to be effective as of the Effective Date (hereinafter
the "Commencement Date") of that certain Merger Agreement by and between
Company, Physician, MIOA and Acquisition Corp (hereinafter the "Merger
Agreement").
WHEREAS, the Company is engaged in the practice of medicine
through physician employees (hereinafter referred to as the "Business"); and
WHEREAS, the Company anticipates merging with and into the
Acquisition Corp whereby Acquisition Corp shall be the surviving corporation in
accordance with the Merger Agreement; and
WHEREAS, the Company and upon effectiveness of the Merger, the
Acquisition Corp, desire to employ Physician and Physician desires to accept or
continue such employment during the term of this Agreement upon the terms and
conditions set forth herein.
NOW, THEREFORE, in consideration of the premises and the mutual
covenants, terms and conditions set forth herein, the Company, Acquisition Corp
and Physician agree as follows:
ARTICLE I
EMPLOYMENT
1.1 EMPLOYMENT AND TITLE. As of the Commencement Date, the Company
employs Physician, and Physician accepts such employment, as President, Medical
Director and a Medical Doctor of the Company, all upon the terms and conditions
set forth herein.
1.2 DEVOTION TO EMPLOYMENT. During the term of this Agreement, Physician shall
faithfully devote his full time, attention, knowledge, energy and skills on
behalf of the Company and as MIOA may otherwise direct, and he shall not engage
in any other gainful employment; provided, however, that nothing contained
herein shall prohibit Physician from performing certain non-patient related
personal services outside his employment by the Company (e.g., speeches
involving honoraria or expert witness services involving expert witness fees) or
from having a financial interest or business arrangement with the facilities
identified in Exhibit "A" attached hereto.
1.3 SERVICES.
1.3.1 During the Term (as hereinafter defined) of this
Agreement, Physician shall at the direction of the Company's CEO and
Board of Directors make decisions about the day-to-day medical and
business operations of the Company.
1.3.2 Physician shall render professional medical services on behalf of
the Company in accordance with all federal, state, AMA and state
medical licensing board regulations, guidelines, practices and
policies, including such duties as may be assigned to him by the
policies committee of the Company whose written communications to
Physician are adopted by the Company as guidelines and incorporated
herein by reference.
1.3.3. Physician shall insure that all medical records,
including, without limitation, doctors notes, progress notes,
discharge notes, patient files, encounter tickets, documents and
reports relative to the Company's patients shall be properly
prepared, filed and maintained in such form as required by insurance
companies, Medicare, Medicaid and/or governmental agencies.
1.3.4. Physician shall also be responsible for managing and
supervising all medical personnel employed by the Company in
connection with the operation of the Company's Business wherever
located.
1.3.5. Physician agrees to assure a standard of medical care
that is consistent with the laws of State of Virginia and the
Federal government with the applicable contractual obligations of
the Company and the prevailing standards of medical practice and
care in the community.
1.3.6. Physician shall be responsible for all aspects of the
practice of medicine and the delivery of medical services for the
Company.
1.3.7. Physician shall assist the Company and MIOA in
expanding their businesses through internal growth as well as
through acquisitions.
1.4 OFFICE LOCATION. The principal place of employment and the
location of Physician's principal office shall be at 13 W. Beverley Street,
Staunton, VA 24401 (the "Office").
1.5 REPRESENTATIONS. Each party represents and warrants to the other
that he/it has full power and authority to enter into and perform this Agreement
and that his/its execution and performance of this Agreement shall not
constitute a default under or breach of any of the terms of any agreement to
which he/it is a party or under which he/it is bound. Other than as provided
herein, each party represents that no consent or approval of any third party is
required for his/its execution, delivery and performance of this Agreement or
that all consents or approvals of any third party required for her/its
execution, delivery and performance of this Agreement have been obtained.
ARTICLE II
TERM
2.1 TERM. The term of Physician's employment hereunder (the "Term")
shall commence as of the Commencement Date and shall continue through the fourth
(4th) anniversary of the Commencement Date (the "Scheduled Termination Date")
unless renewed or earlier terminated pursuant to the provisions of this
Agreement. Unless sooner terminated as set forth herein, this Agreement shall be
automatically renewed after the original four (4) term for successive one (1)
year terms unless the party electing not to renew provides the other party with
written notice of such election at least one thirty (30) days prior to the
Scheduled Termination Date or the last day of the renewal term, as applicable.
ARTICLE III
COMPENSATION AND BENEFITS
3.1 BASE SALARY. As compensation for the services to be rendered by
Physician, the Company shall pay Physician, during the Term of this Agreement,
an annual base salary of Two Hundred Thousand Dollars ($200,000.00) provided
Company profits and cash flow are sufficient to pay such amount. Such base
salary shall accrue monthly (prorated for periods less than a month) and shall
be paid every two (2) weeks, in arrears.
3.2 INCENTIVE COMPENSATION. The Company shall also pay Physician during the term
of this Agreement annual incentive compensation. Such annual incentive
compensation shall be equal to a percentage of the Company's annual pre-tax net
income as determined as of December 31st of each year by the Company's
independent certified accountants based upon generally accepted accounting
principles ("Company Profits") as follows:
3.2.1 Ten (10) percent of Company Profits over $1,000,000.00 through
$1,500,000.00;
3.2.2 Fifteen (15) percent of Company Profits over $1,500,000.00
through $2,000,000.00;
3.2.3 Twenty (20) percent of Company Profits over $2,000,000.00
through $2,500,000.00;
3.2.4 Twenty-five (25) percent of Company Profits over
$2,500,000.00.
Such incentive compensation shall be paid on or before April 1 of
each year for the Company's immediately preceding fiscal year ending December
31st.
3.3 NONQUALIFIED STOCK OPTIONS. As approved by the stock option committee MIOA,
the Company may grant to Physician stock options to acquire MIOA's restricted
common stock.
3.4 BENEFITS. Physician shall be entitled, during the Term hereof, to the same
medical, hospital, pension, profit sharing, dental, disability and life
insurance coverage and benefits as are available to the Company's most senior
executive officers on the Effective Date. In addition, Physician shall be
entitled to such time off with pay for attendance at seminars, courses, meetings
and conventions as is authorized by the Company.
3.5 AUTOMOBILE. Physician, as a condition to his employment, shall provide an
automobile for use in the conduct of his duties on behalf of the Company, and
the Company shall pay to Physician a reasonable allowance determined by the
Company to defray the cost of insurance, gas, oil, repairs, maintenance and
other expenses incurred by Physician in connection with the operation of such
automobile. Any expenses in excess of such allowance shall be the responsibility
of the Physician. Physician shall be required to maintain written records of the
percentage of total miles for which Physician uses such automobile for business
purposes and for personal purposes, respectively.
3.6 WITHHOLDING. Any and all amounts payable under this Agreement, including,
without limitation, amounts payable under this Article III, which are subject to
withholding for such federal, state and local taxes as the Company, in its
reasonable judgment, determines to be required pursuant to any applicable law,
rule or regulation will be subject to the applicable withholding provisions.
ARTICLE IV
WORKING FACILITIES, EXPENSES AND INSURANCE
4.1 WORKING FACILITIES AND EXPENSES. Physician shall be furnished
with an office at the Office of the Company, or at such other location as agreed
to by Physician and the Company, and other working facilities and secretarial
and other assistance suitable to his position and reasonably required for the
performance of his duties hereunder. The Company shall reimburse Physician for
all of Physician's reasonable expenses incurred while employed and performing
his duties under and in accordance with the terms and conditions of this
Agreement, subject to Physician's full and appropriate documentation, including,
without limitation, receipts for all such expenses in the manner required
pursuant to Company's policies and procedures and the Internal Revenue Code of
1986, as amended (the "Code") and applicable regulations as are in effect from
time to time. Such reasonable expenses shall include, without limitation,
licensing costs, continuing medical education and certification costs and the
cost of such medical malpractice, health, life and disability insurance polices
as the parties shall mutually agree.
4.2 INSURANCE. The Company and MIOA may secure in their own names or
otherwise, and at their own expense, life, disability and other insurance
covering Physician or Physician and others, and Physician shall not have any
right, title or interest in or to such insurance other than as expressly
provided herein. Physician agrees to assist the Company and MIOA in procuring
such insurance by submitting to the usual and customary medical and other
examinations to be conducted by such physicians(s) as the Company, MIOA or such
insurance company may designate and by signing such applications and other
written instruments as may be required by any insurance company to which
application is made for such insurance.
ARTICLE V
ILLNESS OR INCAPACITY
5.1 RIGHT TO TERMINATE. If, during the Term of this Agreement,
Physician shall be unable to perform in all material respects his duties
hereunder for a period exceeding six (6) consecutive months by reason of illness
or incapacity, this Agreement may be terminated by the Company in its reasonable
discretion pursuant to Section 7.2 hereof.
5.2 RIGHT TO REPLACE. If Physician's illness or incapacity, whether
by physical or mental cause, renders him unable for a minimum period of thirty
(30) consecutive calendar days to carry out his duties and responsibilities as
set forth herein, the Company shall have the right to designate a person to
replace Physician temporarily in the capacity described in Article I hereof;
provided, however, that if Physician returns to work from such illness or
incapacity within the six (6) month period following his inability due to such
illness or incapacity, he shall be entitled to be reinstated in the capacity
described in Article I hereof with all rights, duties and privileges attendant
thereto.
5.3 RIGHTS PRIOR TO TERMINATION. Physician shall be entitled to his
full remuneration and benefits hereunder during such illness or incapacity
unless and until an election is made by the Company to terminate this Agreement
in accordance with the provisions of this Article.
5.4 DETERMINATION OF ILLNESS OR INCAPACITY. For purposes of this
Article V, the term "illness or incapacity" shall mean Physician's inability to
perform his duties hereunder substantially on a full-time basis due to physical
or mental illness as determined by a qualified, independent physician or
psychiatrist, as the case may be, selected by the Company.
ARTICLE VI
CONFIDENTIALITY
6.1 CONFIDENTIALITY. Physician shall not divulge, communicate, use
to the detriment of the Company, MIOA or any of its subsidiaries, or for the
benefit of any other business, firm, person, partnership or corporation, or
otherwise misuse, any "Confidential Information", pertaining to the Company,
MIOA or any of its subsidiaries including, without limitation, all (i) data or
trade secrets, including secret processes, formulas or other technical data;
(ii) production methods; (iii) patient and customer lists; (iv) personnel lists;
(v) proprietary information; (vi) financial or corporate records; (vii)
operational, sales, promotional and marketing methods and techniques; (viii)
development ideas, acquisition strategies and plans; (ix) financial information
and records; (x) "know-how" and methods of doing business; and (xi) computer
programs, including source codes and/or object codes and other proprietary,
competition-sensitive or technical information or secrets developed with or
without the help of Physician. Physician acknowledges that any such information
or data he may have acquired was received in confidence and by reason of his
relationship to the Company. Confidential Information, data or trade secrets
shall not include any information which: (a) at the time of disclosure is within
the public domain; (b) after disclosure becomes a part of the public domain or
generally known within the industry through no fault, act or failure to act,
error, effort or breach of this Agreement by Physician; (c) is known to the
recipient at the time of disclosure; (d) is subsequently discovered by Physician
independently of any disclosure by the Company or MIOA; (e) is required by
order, statute or regulation, of any governmental authority to be disclosed to
any federal or state agency, court or other body; or (f) is obtained from a
third party who has acquired a legal right to possess and disclose such
information.
6.2 NON-REMOVAL OF RECORDS. All documents, papers, materials, notes, books,
correspondence, drawings and other written and graphic records relating to the
Business of the Company which Physician shall prepare or use, or come into
contact with, shall be and remain the sole property of the Company and,
effective immediately upon the termination of the Physician's employment with
the Company for any reason, shall not be removed from the Company's premises
without the Company's prior written consent or if in Physician's possession or
under his control shall be immediately returned to the Company.
ARTICLE VII
TERMINATION
7.1 TERMINATION FOR CAUSE. This Agreement and the employment of
Physician may be terminated by the Company "For Cause" under any one of the
following circumstances:
(a) Physician commits any material act of fraud, misappropriation
or theft against the Company or MIOA.
(b) Physician's default or breach of any material provision of
this Agreement including without limitation Physician's
failure to faithfully and diligently perform his duties
pursuant to this Agreement; provided, that Physician shall
not be in default or breach hereunder unless he shall have
failed to cure such default or breach within thirty (30)
days of written notice thereof by the Company to Physician.
Notwithstanding, Physician may be terminated pursuant to
this provision if he shall have duly received written
notice on at least two prior instances of the same or
substantially similar breach or default (whether or not
cured by Physician).
(c) Physician engages in gross misconduct or is grossly negligent
in the performance of his duties hereunder.
(d) Physician is convicted of or pleads guilty to a felony offense
which is directly related to his duties and responsibilities
to the Company or that might otherwise materially adversely
affect the Company or Physician's ability to carry out his
duties and responsibilities pursuant to this Agreement.
(e) The loss, or suspension for a period longer than six (6)
months of Physician's license to practice medicine in the
State of Virginia resulting from acts or omissions of
Physician.
(f) Physician not being insurable for professional liability
insurance as the result of acts or omissions on the part of
Physician.
(g) Physician's status as an approved medical provider under the
federal Medicare/Medicaid system being revoked, or suspended
for a period greater than three (3) months.
(h) Physician becoming chemically dependent (as hereinafter
defined) on alcohol or any drugs. Physician shall be
considered to have a "chemical dependency" or to be
"chemically dependent" on alcohol or any drugs if the
Board of Directors of MIOA, in its reasonable discretion,
believes that Physician may be chemically dependent and
requests that Physician submit to an independent medical or
psychological examination, the results of which confirm a
chemical dependency. Physician shall not be terminated for
chemical dependency if this is a first occurrence of
chemical dependency by Physician and Physician enters an
approved treatment program and successfully continues such
program through completion. If Physician refuses to submit
to an independent examination to determine chemical
dependency, or does not successfully complete the treatment
program, or if this is a second or subsequent occurrence of
a chemical dependency, the Company shall be entitled to
terminate this Agreement.
(i) At the election of Physician. and the Company refuses to
consent to such election.
(k) At the election of the Company if the Company sustains net
operating losses (as determined by its accountants ) for any
three (3) consecutive quarterly periods.
A termination For Cause under this Section 7.1 shall be effective
upon the date set forth in a written notice of termination delivered in
accordance with the notice provisions of this Agreement.
7.2 TERMINATION WITHOUT CAUSE. This Agreement and the employment of
the Physician may be terminated "Without Cause" as follows:
(a) By mutual agreement of the parties hereto.
(b) At the election of the Company (which shall be done by its
giving not less than thirty (30) days written notice to
Physician) in the event of an illness or incapacity described
in Article V.
(c) Upon Physician's death.
(d) Upon the removal of Physician from the office of Medical
Director and President of the Company or in the event the
Company fails to afford Physician the power and authority
generally commensurate with the position and the duties
required hereunder.
(e) At the election of the Physician if the Company or MIOA
requires Physician to relocate his residence outside of
Staunton, Virginia.
A termination Without Cause under Section 7.2(b) hereof shall be
effective upon the date set forth in a written notice of termination delivered
in accordance with the notice provisions of such section. A termination Without
Cause under Section 7.2(a) hereof shall be automatically effective upon the date
of mutual agreement. A termination Without Cause under Sections 7.2(c) or (d)
hereof shall be effective upon the date such event takes place. A termination
Without Cause under Section 7.2(e) hereof shall be automatically effective upon
the date of Physician's election.
7.3 EFFECT OF TERMINATION FOR CAUSE. If Physician's employment
is terminated "For Cause":
(a) Physician shall be entitled to accrued base salary under
Section 3.1 hereof through the date of termination.
(b) Physician shall be entitled to receive all benefits as would
have been awarded under Section 3.4 hereof through the date of
termination, which benefits shall be awarded as and when the
same would have been awarded under the Agreement had it not
been terminated.
(c) Physician shall be entitled to reimbursement for expenses
accrued through the date of termination in accordance with the
provisions of Sections 3.5 and 4.1 hereof.
(d) All unpaid incentive compensation and unvested stock options
under Sections 3.2 and 3.3 hereof, respectively, shall be
forfeited. This provision shall also include any "Options" as
that term is defined in those certain Non-qualified Stock
Option Trust dated __________, 1998 of which by virtue of an
addendum to same effective as of the Effective Date Physician
will become a beneficiary.
(e) Except as provided in Article X, this Agreement shall
thereupon terminate and cease to be of any further force or
effect.
7.4 EFFECT OF TERMINATION WITHOUT CAUSE. If Physician's
employment is terminated "Without Cause":
(a) Physician shall be entitled to accrued base salary under
Section 3.1 hereof through the date of termination.
(b) Physician shall be entitled to receive all benefits as would
have been awarded under Section 3.4 hereof through the date of
termination, which benefits shall be awarded as and when the
same would have been awarded under the Agreement had it not
been terminated.
(c) Physician shall be entitled to reimbursement for expenses
accrued through the date of termination in accordance with the
provisions of Sections 3.5 and 4.1 hereof.
(d) Physician shall be entitled to receive all amounts of
incentive compensation as would have been payable under
Section 3.2 hereof through the original Term of this
Agreement, which amounts shall be paid as and when the same
would have been paid under the Agreement had it not been
terminated.
(e) All unvested stock options, if any, under Section 3.3 hereof
shall immediately vest in full.
(f) Physician shall be entitled to a lump sum severance payment in
an amount equal to one hundred twenty thousand dollars
($120,000.00).
(g) Except as provided in Article X, this Agreement shall
thereupon terminate and cease to be of any further force or
effect.
ARTICLE VIII
NON-COMPETITION AND NON-INTERFERENCE
8.1 NONCOMPETITION; CONFIDENTIALITY. As an inducement to the Company
to execute this Agreement and in order to preserve the goodwill associated with
the business of the Company and in addition to and not in limitation of any
covenants contained in any agreement executed and delivered herewith, Physician
hereby covenants and agrees as follows:
A. COVENANT NOT TO COMPETE. During the term of this Agreement
and for a period of two (2) years after its termination "For Cause", Physician
will not directly or indirectly:
(1) be employed by, engage in, continue in or carry
on any business which competes with the Business of the Company or any business
of the Acquisition Corp, MIOA or any of its subsidiaries that is substantially
similar thereto, including owning or controlling any financial interest in any
corporation, partnership, firm or other form of business organization which is
so engaged;
(2) be employed by, consult with, advise or assist
in any way, whether or not for consideration, any corporation, partnership, firm
or other business organization which is now or becomes a competitor of the
Company or the Acquisition Corp in any aspect with respect to the Business of
the Company or the Acquisition Corp, including, but not limited to, advertising
or otherwise endorsing the products of any such competitor; soliciting patients
and customers or otherwise serving as an intermediary for any such competitor;
loaning money or rendering any other form of financial assistance to or engaging
in any form of business transaction on other than on an arm's length basis with
any such competitor;
(3) offer employment to an employee of the Company,
MIOA or any of its subsidiaries, without the prior written consent of MIOA; or
(4) engage in any practice the purpose of which is
to evade the provisions of this covenant not to compete or to commit any act
which adversely affects the Company, the Acquisition Corp or their business;
provided, however, that the foregoing shall not prohibit the
ownership of securities of corporations which are listed on a national
securities exchange or traded in the national over-the-counter market in an
amount which shall not exceed 5% of the outstanding shares of any such
corporation. The parties agree that the geographic scope of this covenant not to
compete shall extend in an outward radius of 15 miles from any clinic, lab,
medical facility or any other business of the Company, Acquisition Corp or any
similar business of any other subsidiary of MIOA. The parties agree that the
Company or the Acquisition Corp, as the case may be, may sell, assign or
otherwise transfer this covenant not to compete, in whole or in part, to any
person, corporation, firm or entity that purchases all or part of the Company's,
or the Acquisition Corp's, business. In the event a court of competent
jurisdiction determines that the provisions of this covenant not to compete are
excessively broad as to duration, geographical scope or activity, it is
expressly agreed that this covenant not to compete shall be construed so that
the remaining provisions shall not be affected, but shall remain in full force
and effect, and any such over broad provisions shall be deemed, without further
action on the part of any person, to be modified, amended and/or limited, but
only to the extent necessary to render the same valid and enforceable in such
jurisdiction.
B. EQUITABLE RELIEF FOR VIOLATIONS. Physician agrees that the
provisions and restrictions contained in this Section are necessary to protect
the legitimate continuing interests of the Company and MIOA and that any
violation or breach of these provisions will result in irreparable injury to the
Company and MIOA for which a remedy at law would be inadequate and that, in
addition to any relief at law which may be available to the Company and/or MIOA
for such violation or breach and regardless of any other provision contained in
this Agreement, the Company and MIOA shall be entitled to injunctive and other
equitable relief as a court may grant after considering the intent of this
Section.
8.2 SEVERABILITY. If any covenant or provision contained in Article
VIII is determined to be void or unenforceable in whole or in part, it shall not
be deemed to affect or impair the validity of any other covenant or provision.
If, in any arbitration or judicial proceeding, a tribunal shall refuse to
enforce all of the separate covenants deemed included in this Article VIII, then
such unenforceable covenants shall be deemed eliminated from the provisions
hereof for the purpose of such proceedings to the extent necessary to permit the
remaining separate covenants to be enforced in such proceedings.
ARTICLE IX
MISCELLANEOUS
9.1 NO WAIVERS. The failure of either party to enforce any provision
of this Agreement shall not be construed as a waiver of any such provision, nor
prevent such party thereafter from enforcing such provision or any other
provision of this Agreement.
9.2 NOTICES. Any notice to be given to the Company and Physician
under the terms of this Agreement may be delivered personally, by telecopy,
telex or other form of written electronic transmission, or by registered or
certified mail, postage prepaid, and shall be addressed as follows:
IF TO THE COMPANY: 13 W. Beverley Street
Masonic Lodge, 2nd floor
Staunton, VA 24401
WITH A COPY TO: Medical Industries of America, Inc.
1903 S. Congress Ave., #400
Boynton Beach, FL 33463
Attn: Paul C. Pershes, President
IF TO PHYSICIAN: David S. Klein, M.D.
13 W. Beverley Street
Masonic Lodge, 2nd floor
Staunton, VA 24401
Either party may hereafter notify the other in writing of any change in
address. Any notice shall be deemed duly given (i) when personally delivered,
(ii) when telecopied, telexed or transmitted by other form of written electronic
transmission (upon confirmation of receipt) or (iii) on the third day after it
is mailed by registered or certified mail, postage prepaid, as provided herein.
9.3 SEVERABILITY. The provisions of this Agreement are severable and
if any provision of this Agreement shall be held to be invalid or otherwise
unenforceable, in whole or in part, the remainder of the provisions, or
enforceable parts thereof, shall not be affected thereby.
9.4 SUCCESSORS AND ASSIGNS. The rights and obligations of the
Company under this Agreement shall inure to the benefit of and be binding upon
the successors, including the Acquisition Corp, and assigns of the Company,
including the survivor upon any merger, consolidation, share exchange or
combination of the Company with any other entity. Physician shall not have the
right to assign, delegate or otherwise transfer any duty or obligation to be
performed by him hereunder to any person or entity.
9.5 ENTIRE AGREEMENT. This Agreement supersedes all prior and
contemporaneous agreements and understandings between the parties hereto, oral
or written, and may not be modified or terminated orally. No modification,
termination or attempted waiver shall be valid unless in writing, signed by the
party against whom such modification, termination or waiver is sought to be
enforced. This Agreement was the subject of negotiation by the parties hereto
and their counsel. The parties agree that no prior drafts of this Agreement
shall be admissible as evidence (whether in any arbitration or court of law) in
any proceeding which involves the interpretation of any provisions of this
Agreement.
9.6 GOVERNING LAW. This Agreement shall be governed by and construed
in accordance with the internal laws of the State of Virginia without reference
to the conflict of law principles thereof.
9.7 SECTION HEADINGS. The section headings contained herein are for
the purposes of convenience only and are not intended to define or limit the
contents of said sections.
9.8 FURTHER ASSURANCES. Each party hereto shall cooperate and shall
take such further action and shall execute and deliver such further documents as
may be reasonably requested by the other party in order to carry out the
provisions and purposes of this Agreement.
9.9 GENDER. Whenever the pronouns "he" or "his" are used herein they
shall also be deemed to mean "she" or "her" or "it" or "its" whenever
applicable. Words in the singular shall be read and construed as though in the
plural and words in the plural shall be read and construed as though in the
singular in all cases where they would so apply.
9.10 COUNTERPARTS. This Agreement may be executed in counterparts,
all of which taken together shall be deemed one original.
<PAGE>
ARTICLE X
SURVIVAL
10.1 SURVIVAL. The provisions of Articles VI, VII, VIII, and IX, of this
Agreement shall survive the termination of this Agreement.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement
as of the date first above written.
MIAO ACQUISTION COMPANY V, INC. DAVID S. KLEIN, M.D., P.C.
By: /s/ PAUL C. PERSHES By: /s/ DAVID S. KLEIN
Title: President
EMPLOYEE
/s/ DAVID S. KLEIN M.D.
David S. Klein, M.D.
